Processing 00000000.tx.1: -Synuclein Expression Levels Do Not Significantly Affect Proteasome Function and Expression in Mice and Stably Transfected PC12 Cell Lines* Begoa Martn-Clemente, Beatriz Alvarez-Castelao, Isabel Mayo||, Ana Beln Sierra, Virginia Daz, Miguel Miln**, Isabel Farias**, Teresa Gmez-Isla, Isidro Ferrer, and Jos G. 

Phrase: "-Synuclein Expression Levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "Do"

Phrase: "Not Significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "Affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "Proteasome Function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "Expression in Mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Stably Transfected PC12 Cell Lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0007600:Cell lines [Cell]
   840   C0085262:PC12 Cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "* Begoa Martn-Clemente,"

Phrase: "Beatriz Alvarez-Castelao,"

Phrase: "Isabel Mayo||,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454788:Mayo [Geographic Area]
   861   C1077578:mayo [Plant]

Phrase: "Ana Beln Sierra,"

Phrase: "Virginia Daz,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0067356:daz [Organic Chemical]
   861   C1539219:DAZ [Gene or Genome]

Phrase: "Miguel Miln"

Phrase: "*"

Phrase: "*,"

Phrase: "Isabel Farias"

Phrase: "*"

Phrase: "*,"

Phrase: "Teresa Gmez-Isla,"

Phrase: "Isidro Ferrer,"

Phrase: "and"

Phrase: "Jos G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: Castao From the Departamento de Bioqumica e Instituto de Investigaciones Biomdicas "Alberto Sols," Universidad Autnoma de Madrid-Consejo Superior de Investigaciones Cientfica, Facultad de Medicina UAM, 28029 Madrid, Spain, the **Departamento de Biologa Celular, Facultad de Biolgicas, Universidad de Valencia, 46100 Valencia, Spain, the Departamento de Neurociencias, Clnica Universitaria de Navarra, 31008 Pamplona, Spain, and the Instituto de Neuropatologa, Servicio de Anatoma Patolgica, Hospital Universitario de Bellvitge, 08907 Hospitalet de Llobregat, Spain Received for publication, August 6, 2004 , and in revised form, September 24, 2004.  

Phrase: "Castao"

Phrase: "From the Departamento de Bioqumica e Instituto de Investigaciones Biomdicas ""Alberto Sols,"" Universidad Autnoma de Madrid-Consejo Superior de Investigaciones Cientfica,"

Phrase: "Facultad de Medicina UAM,"

Phrase: "28029 Madrid,"

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "the **Departamento de Biologa Celular,"

Phrase: "Facultad de Biolgicas,"

Phrase: "Universidad de Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1217267:Valencia [Fish]
   755 E C1553365:Valencian [Population Group]

Phrase: "46100 Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1217267:Valencia [Fish]
   789 E C1553365:Valencian [Population Group]

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "the Departamento de Neurociencias,"

Phrase: "Clnica Universitaria de Navarra,"

Phrase: "31008 Pamplona,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1677144:Pamplona [Eukaryote]

Phrase: "Spain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "and"

Phrase: "the Instituto de Neuropatologa,"

Phrase: "Servicio de Anatoma Patolgica,"

Phrase: "Hospital Universitario de Bellvitge,"

Phrase: "08907 Hospitalet de Llobregat,"

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "August 6,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "September 24,"

Phrase: "2004."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  -Synuclein (-syn) is a small protein of unknown function that is found aggregated in Lewy bodies, the histopathological hallmark of sporadic Parkinson disease and other synucleinopathies. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES  -Synuclein (-syn)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a small protein of unknown function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "aggregated in Lewy bodies,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C0332621:Aggregated [Functional Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0205418:Aggregate [Qualitative Concept]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "the histopathological hallmark of sporadic Parkinson disease"

Phrase: "and"

Phrase: "other synucleinopathies."
Processing 00000000.tx.4: Mutations in the -syn gene and a triplication of its gene locus have been identified in early onset familial Parkinson disease. 

Phrase: "Mutations in the -syn gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "a triplication of its gene locus"

Phrase: "have"

Phrase: "been"

Phrase: "identified in early onset familial Parkinson disease."
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   800   C0814120:early disease onset [Disease or Syndrome]
   778   C0030567:Parkinson Disease [Disease or Syndrome]
   778   C1521736:Parkinson's Disease [Functional Concept]
   778   C1833334:Early-onset [Finding]
   778   C2681933:PARKINSON DISEASE [Gene or Genome]
   774   C0277558:Familial disease [Disease or Syndrome]
   774   C0277793:disease onset [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0205396:Identified [Qualitative Concept]
   748   C0241888:Familial [Functional Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   738 E C0344339:disease family [Finding]
Processing 00000000.tx.5: -Syn turnover can be mediated by the proteasome pathway. 

Phrase: "-Syn turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "can"

Phrase: "be"

Phrase: "mediated by the proteasome pathway."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   770 E C1523807:proteasomal pathway [Molecular Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1325620:proteasome [Cell Component]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.6: A survey of published data may lead to the suggestion that overexpression of -syn wild type, and/or their variants (A53T and A30P), may produce a decrease in proteasome activity and function, contributing to -syn aggregation. 

Phrase: "A survey of published data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0038951:Survey [Intellectual Product]

Phrase: "may"

Phrase: "lead to the suggestion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0038659:Suggestion [Idea or Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1705535:suggestion [Idea or Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that overexpression of -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "wild type,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and/or"

Phrase: "their variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "(A53T"

Phrase: "and"

Phrase: "A30P"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "produce"

Phrase: "a decrease in proteasome activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "contributing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contributing [Activity]

Phrase: "to -syn aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.7: To investigate the relationship between synuclein expression and proteasome function we have studied proteasome peptidase activities and proteasome subunit expression (, -constitutive, and inducible) in mice either lacking -syn (knock-out mice) or transgenic for human -syn A30P (under control of PrP promoter, at a time when no clear gliosis can be observed). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the relationship between synuclein expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "studied proteasome peptidase activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C1622946:proteasome activity [Molecular Function]
   844   C1150095:peptidase activity [Molecular Function]
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "proteasome subunit expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(, -"

Phrase: "constitutive,"

Phrase: "and"

Phrase: "inducible"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Inducible [Functional Concept]
  1000   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "in mice either lacking -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(knock-out mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0560617:knock out [Injury or Poisoning]
   734   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ")"

Phrase: "or"

Phrase: "transgenic for human -syn A30P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003069:Transgenic [Animal]

Phrase: "("

Phrase: "under control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of PrP promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at a time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "when"

Phrase: "no clear gliosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017639:Gliosis [Pathologic Function]

Phrase: "can"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ")."
Processing 00000000.tx.8: Similar studies are presented in PC12 cells overexpressing enhanced yellow fluorescent protein fusion constructs of human wild type, A30P, and A53T -syn. 

Phrase: "Similar studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "presented in PC12 cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   770   C0007634:Cells [Cell]
   770   C0449450:Presented [Idea or Concept]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C3282337:Cells [Cell]
   737 E C0150312:Present [Quantitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "enhanced yellow fluorescent protein fusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "constructs of human wild type, A30P,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0086418:Human [Human]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "A53T -syn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.9: In these cell lines we have also analyzed the assembly of 20 S proteasome complex and the degradation rate of a well known substrate of the proteasome pathway, Ib. 

Phrase: "In these cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "also"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the assembly of 20 S proteasome complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1523886:proteasome complex assembly [Molecular Function]
           proteasome assembly
   748   C1706853:Assembly [Activity]
   748   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "the degradation rate of a well known substrate of the proteasome pathway,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C1511758:Degradation Pathway [Conceptual Entity]
   736   C0243125:degradation [Functional Concept]
   736   C0699900:Degradation [Organism Function]
   736   C0871208:Rate [Activity]
   736   C1521828:Rate [Quantitative Concept]

Phrase: "Ib."
Processing 00000000.tx.10: Overall the data obtained led us to the conclusion that -synuclein expression levels by themselves have no significant effect on proteasome peptidase activity, subunit expression, and proteasome complex assembly and function. 

Phrase: "Overall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to the conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707478:Conclusion [Idea or Concept]

Phrase: "that -synuclein expression levels by themselves"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "no significant effect on proteasome peptidase activity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "subunit expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "proteasome complex assembly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1523886:proteasome complex assembly [Molecular Function]
           proteasome assembly
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.11: These results strengthen the suggestion that other mechanisms resulting in synuclein aggregation (not simply expression levels) may be the key to understand the possible effect of aggregated synuclein on proteasome function.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "strengthen"

Phrase: "the suggestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038659:Suggestion [Idea or Concept]
  1000   C1705535:suggestion [Idea or Concept]

Phrase: "that"

Phrase: "other mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "resulting in synuclein aggregation"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332294:Resulting in [Functional Concept]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "("

Phrase: "not simply expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "the key to"

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the possible effect of aggregated synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on proteasome function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Idiopathic Parkinson disease (PD),1 dementia with Lewy bodies, a Lewy body variant of Alzheimer's disease, and multiple system atrophy are characterized pathologically by proteinaceous inclusions commonly referred to as Lewy pathology in postmortem brain tissue samples (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Idiopathic Parkinson disease (PD),"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030567:Idiopathic Parkinson Disease [Disease or Syndrome]
           Parkinson Disease
   913   C0277553:Idiopathic disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0332240:Idiopathic [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]

Phrase: "1 dementia with Lewy bodies,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   926   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   827 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "a Lewy body variant of Alzheimer's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "multiple system atrophy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "are"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "pathologically by proteinaceous inclusions commonly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1512693:Inclusion [Qualitative Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "Lewy pathology in postmortem brain tissue samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0006119:Brain Pathology [Pathologic Function]
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0677042:pathology [Pathologic Function]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: The inclusions occur in the dystrophic (Lewy) neurites that constitute an important part of the pathology of PD and dementia with Lewy bodies. 

Phrase: "The inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "occur in the dystrophic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0333607:Dystrophic [Functional Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "(Lewy) neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C3548404:Lewy neurite [Cell Component]
   861   C0085103:Neurites [Cell Component]

Phrase: "that"

Phrase: "constitute"

Phrase: "an important part of the pathology of PD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "dementia with Lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.14: -Synuclein is the major constituent of Lewy bodies and Lewy neurites (35). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the major constituent of Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0729650:constituent [Substance]

Phrase: "and"

Phrase: "Lewy neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C3548404:Lewy neurite [Cell Component]
   861   C0085103:Neurites [Cell Component]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.15: The initial discovery of two point mutations (A53T and A30P) in the -syn gene linked to early onset familial PD (6), together with the recently described E46K mutation (7), the ability of the protein to self-aggregate (8), and recent findings in vivo in transgenic flies and mice (see for review Refs. 9 and 10) are supporting a central role for -synuclein in the pathophysiology of diseases with Lewy body pathology. 

Phrase: "The initial discovery of two point mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880355:Discovery [Activity]

Phrase: "(A53T"

Phrase: "and"

Phrase: "A30P"

Phrase: ")"

Phrase: "in the -syn gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "linked to early onset familial PD"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   800   C0814120:early disease onset [Disease or Syndrome]
   778   C0030567:Parkinson Disease [Disease or Syndrome]
   778   C1521736:Parkinson's Disease [Functional Concept]
   778   C1833334:Early-onset [Finding]
   778   C2681933:PARKINSON DISEASE [Gene or Genome]
   774   C0277558:Familial disease [Disease or Syndrome]
   774   C0277793:disease onset [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   738 E C0344339:disease family [Finding]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "together with the recently described E46K mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "the ability of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "to self-aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:Aggregate [Qualitative Concept]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "in vivo in transgenic flies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "("

Phrase: "see for review Refs. 9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0042789:see [Organism Function]
   760   C0282443:Review [Intellectual Product]
   760   C1425988:REF [Gene or Genome]
   760   C1552617:Review [Idea or Concept]
   760   C1947903:See [Activity]

Phrase: "and"

Phrase: "10"

Phrase: ")"

Phrase: "are"

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a central role for -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the pathophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031847:pathophysiology [Functional Concept]
  1000   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "of diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "with Lewy body pathology."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0085200:Lewy Body [Cell Component]
Processing 00000000.tx.16: The proteasome pathway can mediate the degradation of -syn. 

Phrase: "The proteasome pathway"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1752727:Proteasome Pathway [Molecular Function]
   964 E C1523807:proteasomal pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "can"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the degradation of -syn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.17: The work of several authors (1113) clearly indicates that -syn can be directly degraded by the 20 S proteasome without requirement of prior ubiquitylation, even when fused to glutathione S-transferase or enhanced green fluorescent protein (13). 

Phrase: "The work of several authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043227:Work [Occupational Activity]

Phrase: "(1113"

Phrase: ")"

Phrase: "clearly"

Phrase: "indicates"

Phrase: "that -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "degraded by the 20 S proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1752727:Proteasome [Molecular Function]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "without requirement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Requirement [Functional Concept]

Phrase: "of prior ubiquitylation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519751:Ubiquitylation [Molecular Function]

Phrase: "even"

Phrase: "when"

Phrase: "fused to glutathione S-transferase"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   862   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   760   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0699952:Fused [Functional Concept]
   726 E C1414861:FUSE [Gene or Genome]
   726 E C1708111:Fuse [Manufactured Object]

Phrase: "or"

Phrase: "enhanced green fluorescent protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   923   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0332583:Green [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.18: Accordingly a decrease in proteasome activity may impair -syn degradation and then facilitate its aggregation. 

Phrase: "Accordingly"

Phrase: "a decrease in proteasome activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "may"

Phrase: "impair -syn degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "facilitate"

Phrase: "its aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.19: Supporting the above conclusion several reports have described that proteasome inhibitors promote -syn aggregation in neurons (1416), neuronal-like cell lines (12, 1719), and non-neuronal cell lines (20, 21). 

Phrase: "Supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the above conclusion several reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0684224:Reports [Intellectual Product]
   812   C0700287:reports [Health Care Activity]
   779 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "that proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "promote -syn aggregation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0033414:Promote [Activity]
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(1416"

Phrase: ")"

Phrase: ","

Phrase: "neuronal-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "like cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "(12,"

Phrase: "1719"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "non-neuronal cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   923   C0027836:Non-neuronal cell [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.20: These results by themselves are not unexpected, as many different pathogenic proteins aggregate when they are overexpressed in cells as a consequence of proteasome inhibition (see for example Ref. 22). 

Phrase: "These results by themselves"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "are"

Phrase: "not unexpected,"

Phrase: "as"

Phrase: "many different pathogenic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "when"

Phrase: "they"

Phrase: "are"

Phrase: "overexpressed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756   C1514559:overexpress [Genetic Function]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "as a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "("

Phrase: "see for example Ref. 22"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0042789:see [Organism Function]
   760   C1425988:REF [Gene or Genome]
   760   C1707959:Example [Conceptual Entity]
   760   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.21: The possible relevance of proteasome activity in PD pathology is highlighted by reports that describe a decrease in the proteasome peptidase activity in the substantia nigra of sporadic PD patients (23, 24), accompanied with a decreased expression of proteasomal -subunits (but not -type subunits) of the proteasome in the same brain region (25). 

Phrase: "The possible relevance of proteasome activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevance [Qualitative Concept]

Phrase: "in PD pathology"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "is"

Phrase: "highlighted by reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0684224:Reports [Intellectual Product]
   790   C0700287:reports [Health Care Activity]
   756 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "describe"

Phrase: "a decrease in the proteasome peptidase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "of sporadic PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "accompanied with a decreased expression of proteasomal -subunits"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   711 E C0547047:Decrease [Quantitative Concept]
   711   C1711351:Subunit [Quantitative Concept]

Phrase: "("

Phrase: "but"

Phrase: "not -type subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: ")"

Phrase: "of the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "in the same brain region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:Brain region [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.22: Nevertheless, other authors have found no change of proteasome peptidase activity in human brain regions with dementia with Lewy bodies pathology (26). 

Phrase: "Nevertheless,"

Phrase: "other authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no change of proteasome peptidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0442739:No change [Finding]
   790   C1548568:No change [Intellectual Product]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "in human brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "with Lewy bodies pathology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0085200:Lewy Bodies [Cell Component]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.23: Another line of circumstantial evidence is the report by several groups that synuclein overexpression produces a decrease of proteasome peptidase activity when assayed in crude extracts obtained from stably transfected cell lines (17, 19, 27), and in vitro studies reporting that -synuclein (and the aggregated form of -syn at lower concentrations) inhibits the peptidase activity of the proteasome (27, 28). 

Phrase: "Another line of circumstantial evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205132:Line [Spatial Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "the report by several"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "that synuclein overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "produces"

Phrase: "a decrease of proteasome peptidase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "when"

Phrase: "assayed in crude extracts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1258023:Crude Extracts [Chemical]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737   C2828366:Extract [Substance]

Phrase: "obtained from stably transfected cell lines"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1301820:Obtained [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "(17,"

Phrase: "19,"

Phrase: "27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "and"

Phrase: "the aggregated form of -syn at lower concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the peptidase activity of the proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1150095:peptidase activity [Molecular Function]
   783   C1622946:proteasome activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.24: The possible pathological connection between synuclein overexpression and human PD is also suggested by the recent finding of a gene triplication in the so called "Iowa kindred" with an autosomal-dominant familial form of PD (29) and by -syn overexpression in the substantia nigra of a set of PD patients (30), whereas -syn overexpression in sporadic PD patients has not been confirmed in other studies (see Ref. 31 and references within) One emergent suggestion from all these data is that -synuclein overexpression may directly produce a decrease in proteasome function, initiating a positive reinforcing loop that results in the formation of aggregated synuclein that will promote further proteasome inhibition and synuclein aggregation. 

Phrase: "The possible pathological connection between synuclein overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449379:Connection [Intellectual Product]

Phrase: "and"

Phrase: "human PD"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]

Phrase: "is"

Phrase: "also"

Phrase: "suggested by the recent finding of a gene triplication"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0017337:Gene [Gene or Genome]
   742   C0037088:Finding [Sign or Symptom]
   742   C0243095:Finding [Finding]
   742   C0332185:Recent [Temporal Concept]
   742   C2825141:Finding [Finding]
   708   C1705535:Suggest [Idea or Concept]

Phrase: "in the so called ""Iowa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022037:Iowa [Geographic Area]
   827   C1555231:Iowa [Population Group]

Phrase: "kindred"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598429:kindred [Qualitative Concept]

Phrase: "with an autosomal-dominant familial form"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1832428:Familial form [Finding]
   812   C0348078:Form [Qualitative Concept]
   812   C0376315:Form [Manufactured Object]
   812   C1522492:Form [Functional Concept]

Phrase: "of PD"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(29"

Phrase: ")"

Phrase: "and by -syn overexpression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1514559:Overexpression [Genetic Function]
   770   C1515981:And [Idea or Concept]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "of a set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "of PD patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "whereas -syn overexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514559:Overexpression [Genetic Function]

Phrase: "in sporadic PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "confirmed in other studies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0521093:confirmed [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C2603343:Study [Research Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450355:31 [Intellectual Product]
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "references within"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1514811:Reference [Idea or Concept]
   833   C1706462:Reference [Conceptual Entity]

Phrase: ")"

Phrase: "One emergent suggestion from all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038659:Suggestion [Idea or Concept]
   760   C1705535:suggestion [Idea or Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "is"

Phrase: "that -synuclein overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "may"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "produce"

Phrase: "a decrease in proteasome function,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "initiating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "a positive reinforcing"

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "that results in the formation of aggregated synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "that"

Phrase: "will"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "further proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "synuclein aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.25: As a consequence we decided to explore the relationship between synuclein expression levels and proteasome function. 

Phrase: "As a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the relationship between synuclein expression levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "proteasome function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.26: To that end we have studied proteasome peptidase activities and proteasome subunit expression in mice, either lacking -syn (knock-out mice), or transgenic for human -syn A30P, and also in PC12 cells overexpressing EYFP fusion constructs of human wild type, A30P, and A53T -syn. 

Phrase: "To that"

Phrase: "end"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]

Phrase: "we"

Phrase: "have"

Phrase: "studied proteasome peptidase activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C1622946:proteasome activity [Molecular Function]
   844   C1150095:peptidase activity [Molecular Function]
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "proteasome subunit expression in mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "either lacking -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(knock-out mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0560617:knock out [Injury or Poisoning]
   734   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "transgenic for human -syn A30P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "also in PC12 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   770   C0007634:Cells [Cell]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "EYFP fusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "constructs of human wild type, A30P,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0086418:Human [Human]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "A53T -syn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.27: Finally to address the issue of proteasome function in situ we have analyzed the assembly of 20 S proteasome and the degradation rate of a well known substrate of the proteasome, Ib, in the -syn overexpressing PC12 cell lines. 

Phrase: "Finally to"

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the issue of proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033213:Issue [Finding]
   770   C1706387:Issue [Intellectual Product]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "in situ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444498:In situ [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the assembly of 20 S proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1523886:proteasome assembly [Molecular Function]
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "the degradation rate of a well known substrate of the proteasome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]
   738   C0871208:Rate [Activity]
   738   C1521828:Rate [Quantitative Concept]

Phrase: "Ib,"

Phrase: "in the -syn overexpressing PC12 cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0007600:Cell lines [Cell]
   840   C0085262:PC12 Cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.28: The data obtained clearly suggest that synuclein expression levels by themselves have no significant effect on proteasome expression and function.  

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "clearly"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that synuclein expression levels by themselves"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "no significant effect on proteasome expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.29: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Plasmid ConstructsHuman wild type -syn cDNA was obtained by PCR with the appropriate oligonucleotides from a human placental cDNA library and cloned into the NdeI and SalI sites of pT7-7 vector. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Plasmid ConstructsHuman wild type -syn cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "obtained by PCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with the appropriate oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from a human placental cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   812   C0023621:Library [Manufactured Object,Organization]
   812   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cloned into the NdeI"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0009013:cloned [Cell]
   737 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "SalI sites of pT7-7 vector."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.30: pT7--syn A30P and A53T were also obtained by PCR with QuikChangeTM site-directed mutagenesis kit from Stratagene. 

Phrase: "pT7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421837:pT7 [Gene or Genome]

Phrase: "--syn A30P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "A53T"

Phrase: "were"

Phrase: "also"

Phrase: "obtained by PCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with QuikChangeTM site-directed mutagenesis kit"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0812225:KIT [Medical Device]
   804   C1150635:KIT [Molecular Function]
   804   C1705212:Kit [Medical Device]
   804   C1705213:KIT [Medical Device]
   804   C3273202:Kit [Manufactured Object]
   717   C0079870:Mutagenesis, Site-Directed [Genetic Function]

Phrase: "from Stratagene."
Processing 00000000.tx.31: pEYFP--syn was obtained by subcloning the amplified -syn into the XhoI site of pEYFP-C1 vector. 

Phrase: "pEYFP"

Phrase: "--syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "obtained by subcloning"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the amplified -syn into the XhoI site of pEYFP-C1 vector."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.32: The untagged versions of synuclein were obtained by subcloning the amplified -syn into the NheI/XhoI sites of pcDNA3.1 Zeo. 

Phrase: "The untagged versions of synuclein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: "were"

Phrase: "obtained by subcloning"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the amplified -syn into the NheI/XhoI sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of pcDNA3.1 Zeo."
Processing 00000000.tx.33: The constructs of variants syn A30P and A53T were obtained by PCR using the same mutagenesis kit from Stratagene. 

Phrase: "The constructs of variants syn A30P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "A53T"

Phrase: "were"

Phrase: "obtained by PCR"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same mutagenesis kit from Stratagene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0812225:KIT [Medical Device]
   753   C1150635:KIT [Molecular Function]
   753   C1705212:Kit [Medical Device]
   753   C1705213:KIT [Medical Device]
   753   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.34: All constructs were fully sequenced by the chain termination method. 

Phrase: "All constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "fully"

Phrase: "sequenced by the chain termination method."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0025663:Method [Intellectual Product]
   753   C0337112:Chain [Manufactured Object]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C1524075:Chain [Idea or Concept]
   753   C1549081:Termination [Intellectual Product]
   753   C1692758:termination [Idea or Concept]
   719   C0004793:Sequence [Nucleotide Sequence]
   719   C0162326:Sequence [Nucleotide Sequence]
   719   C0162327:Sequence [Nucleotide Sequence]
   719   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.35: Synuclein Purification and Generation of Polyclonal Antibodies Wild type, A30P, and A53T synucleins were purified essentially as described (32), adding one final step of purification by loading -synuclein into a DEAE-5PW HPLC column and elution with a linear gradient from 50 mM to 0.6 M NaCl in 50 mM Tris-Cl, pH 7.5. 

Phrase: "Synuclein Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "Generation of Polyclonal Antibodies Wild type, A30P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "A53T synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "essentially"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "one final step of purification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0534010:one step [Biomedical or Dental Material,Organic Chemical]
   760   C1261552:Step [Conceptual Entity]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]

Phrase: "by loading -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "into a DEAE-5PW HPLC column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "elution with a linear gradient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441565:Elution [Laboratory Procedure]

Phrase: "from 50 mM"

Phrase: "to 0.6 M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "in 50 mM Tris-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "pH 7.5."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.36: All proteins were dialyzed against ddH20 or 25 mM Tris-Cl, pH 7.5, and stored frozen at 70 C until use. 

Phrase: "All proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "dialyzed against ddH20"

Phrase: "or"

Phrase: "25 mM Tris-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "frozen at 70 C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0677542:Frozen [Functional Concept]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.37: Antibodies against -syn were obtained in rabbits by immunization with the purified protein (100 g/injection), as described (33). 

Phrase: "Antibodies against -syn"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained in rabbits"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0034493:Rabbit [Mammal]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with the purified protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100 g/injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021485:injection [Therapeutic or Preventive Procedure]
   827   C1272883:Injection [Biomedical or Dental Material]
   827   C1533685:Injection [Therapeutic or Preventive Procedure]
   827   C1828121:Injection [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.38: Mouse Animal ModelsSynuclein knock-out mice (/) and their corresponding control mice (+/+) have been described previously (34). 

Phrase: "Mouse Animal ModelsSynuclein knock-out mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0206745:Knock-out Mice [Mammal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(/"

Phrase: ")"

Phrase: "and"

Phrase: "their corresponding control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(+/+"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.39: Transgenic mice for human A30P -syn under the control of PrP promoter (C57B/6jxSJL F3, Tg5093, and Tg5102, Tg+/) and the corresponding control mice (Tg /) have been described previously (35), the samples analyzed were from 4-month old transgenic mice where no substantial gliosis is apparent (35). 

Phrase: "Transgenic mice for human A30P -syn"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of PrP promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(C57B/6jxSJL F3,"

Phrase: "Tg5093,"

Phrase: "and"

Phrase: "Tg5102,"

Phrase: "Tg+/)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337445:TG [Laboratory Procedure]

Phrase: "and"

Phrase: "the corresponding control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(Tg /)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337445:TG [Laboratory Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "were from 4-month old transgenic mice where"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0025936:Mice, Transgenic [Mammal]
   744   C0003069:Transgenic [Animal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0439231:month [Temporal Concept]
   744   C0439507:/month [Temporal Concept]
   744   C0580836:Old [Temporal Concept]

Phrase: "no substantial gliosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017639:Gliosis [Pathologic Function]

Phrase: "is"

Phrase: "apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.40: Mice were anesthetized and whole brains were removed. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "anesthetized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720436:Anesthetized [Finding]

Phrase: "and"

Phrase: "whole brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]
Processing 00000000.tx.41: Fresh brains were subjected to dissection for obtaining the cerebral cortex, cerebellum, striatum, and ventral midbrain (containing the substantia nigra and ventral tegmental area). 

Phrase: "Fresh brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "subjected to dissection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0012737:Dissection [Therapeutic or Preventive Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "for obtaining"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   966   C1301820:Obtain [Functional Concept]
   966   C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "("

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.42: All tissue samples were immediately frozen in liquid nitrogen and stored at 80 C until processed. 

Phrase: "All tissue samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1292533:Tissue Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "frozen in liquid nitrogen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]

Phrase: "and"

Phrase: "stored at 80 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "processed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.43: Transfected Cell Lines, Metabolic Labeling, and ImmunoprecipitationsRat PC12 cells were transfected with pEYFP-syn plasmids, and stable transfectants were selected with Geneticin and further enriched by fluorescence-activated cell sorting. 

Phrase: "Transfected Cell Lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "Metabolic Labeling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "ImmunoprecipitationsRat PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with pEYFP-syn plasmids,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "stable transfectants"

Phrase: "were"

Phrase: "selected with Geneticin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0119053:Geneticin [Organic Chemical,Pharmacologic Substance]
   756   C1707391:Select [Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "enriched by fluorescence-activated cell sorting."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   882   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]
   790   C0007616:Cell Sorting [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0237886:Sorting [Mental Process]
   753   C0359583:enriched [Food]
   753   C0700314:sorting [Cell Function]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1879547:Activated [Activity]
   753   C1947906:Sorting [Activity]
   753   C1948049:Cell [Spatial Concept]
   719 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.44: The expression of EYFP--syn (syn wt, A30P, and A53T) fusion proteins was analyzed by Western immunoblotting of total cell extracts prepared by direct lysis of cells in SDS-loading buffer and separation on 14% SDS-PAGE (see below). 

Phrase: "The expression of EYFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "--syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(syn wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "A30P,"

Phrase: "and"

Phrase: "A53T"

Phrase: ")"

Phrase: "fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "analyzed by Western immunoblotting of total cell extracts"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C0005863:Western Immunoblotting [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0007592:Cell Extracts [Cell Component]
   754 E C0949466:Western Immunoblot [Laboratory Procedure]
   744   C0007634:Cell [Cell]
   744   C0020985:Immunoblotting [Laboratory Procedure]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0936012:Analyzed [Research Activity]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1705493:Western [Spatial Concept]
   744   C1948049:Cell [Spatial Concept]
   711   C2828366:Extract [Substance]

Phrase: "prepared by direct lysis of cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0007634:Cells [Cell]
   753   C0024348:Lysis [Pathologic Function]
   753   C0439851:Direct [Qualitative Concept]
   753   C1536403:lysis [Cell Function]
   753   C1947931:Direct [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1521827:Prepare [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in SDS-loading buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "separation on 14% SDS-PAGE ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.45: Protein turnover was studied by the treatment of cells with cycloheximide (50 g/ml) for the times indicated, and immunoblotting of total cell extracts with anti-Ib, as indicated above. 

Phrase: "Protein turnover"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597297:Protein Turnover [Molecular Function]
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "was"

Phrase: "studied by the treatment of cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   767   C3161471:Treatment Study [Research Activity]
   753   C0007634:Cells [Cell]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3282337:Cells [Cell]
   753   C3538994:TREATMENT [Research Activity]
   719   C0557651:Study [Manufactured Object]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719   C2603343:Study [Research Activity]

Phrase: "with cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(50 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) for the times"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "and"

Phrase: "immunoblotting of total cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "extracts with anti-Ib,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2828366:Extract [Substance]

Phrase: "as"

Phrase: "indicated above."
Processing 00000000.tx.46: Cells were metabolically labeled with 200 Ci/ml of [35S]methionine/cysteine (Amersham Biosciences) for 1 h (pulse) in Dulbecco's modified Eagle's medium without methionine/cysteine and then chased for different periods of time with complete medium. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "metabolically"

Phrase: "labeled with 200 Ci/ml of [35S"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C2348025:Ci/mL [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "]methionine/cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "for 1 h (pulse"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0391850:Pulse [Physiologic Function]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]
   734   C0700308:1 H [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "without methionine/cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "chased for different periods of time"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0439582:Time periods [Temporal Concept]
   756 E C0585019:Temporal periods [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C3541383:Time [Temporal Concept]
   748   C1442103:Time Difference [Temporal Concept]
   748   C1547049:*Time Difference [Quantitative Concept]
   719   C0439531:/period [Temporal Concept]
   719   C1948053:Period [Temporal Concept]

Phrase: "with complete medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.47: At the times indicated, cells were washed with cold phosphate-buffered saline (2 x) and lysed in immunoprecipitation buffer (Tris-buffered saline (50 mM Tris-Cl, pH 7.5, 150 mM NaCl) containing 0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 1 g/ml pepstatin, 10 M of leupeptin, and 10 M MG132 (Calbiochem)). 

Phrase: "At the times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with cold phosphate-buffered saline"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C0234192:Cold [Physiologic Function]
   753   C1548982:Washed [Idea or Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719 E C0441648:Wash [Activity]

Phrase: "(2 x)"

Phrase: "and"

Phrase: "lysed in immunoprecipitation buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C0024348:lysed [Pathologic Function]

Phrase: "(Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(50 mM Tris-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "10 M of leupeptin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "10 M MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.48: Lysed cells were kept on ice for 5 min and centrifuged at 15,000 x g for 30 min at 4 C to remove any insoluble material. 

Phrase: "Lysed cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "kept on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0333118:Keep [Functional Concept]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "centrifuged at 15,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "any insoluble material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]
Processing 00000000.tx.49: The supernatants were used directly for immunoprecipitation. 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "directly for immunoprecipitation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.50: Immunoprecipitations were performed with rabbit anti-proteasome (36) or anti-Ib (Santa Cruz Biotechnology, sc-847) antibodies previously coupled to protein A-Sepharose (Amersham Biosciences) as described previously (36). 

Phrase: "Immunoprecipitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "were"

Phrase: "performed with rabbit"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0034493:Rabbit [Mammal]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "anti-proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "(36"

Phrase: ")"

Phrase: "or"

Phrase: "anti-Ib (Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "sc-847"

Phrase: ")"

Phrase: "antibodies previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "coupled to protein A-Sepharose"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   862   C0075172:protein A-sepharose [Carbohydrate]
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C1948027:Coupled [Functional Concept]
   726 E C0010222:couple [Family Group]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.51: The immunoprecipitated proteins were eluted with SDS-sample buffer and analyzed by 10% SDS-PAGE and autoradiography. 

Phrase: "The immunoprecipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with SDS-sample buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "analyzed by 10% SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0936012:Analyzed [Research Activity]
   760   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.52: Proteasome Activity and ImmunoblottingBrain tissue samples were processed for the determination of proteasome peptidase activities and immunoblotting as follows. 

Phrase: "Proteasome Activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "ImmunoblottingBrain tissue samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1292533:Tissue Sample [Tissue]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "processed for the determination of proteasome peptidase activities"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   754   C1150095:peptidase activity [Molecular Function]
   750   C1622946:proteasome activity [Molecular Function]
   744   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0441655:Activities [Activity]
   744   C1148554:determination [Laboratory Procedure]
   744   C1325620:proteasome [Cell Component]
   744   C1522240:Processed [Phenomenon or Process]
   744   C1752727:Proteasome [Molecular Function]
   744   C1947941:Peptidase [Enzyme]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1184743:Process [Body Part, Organ, or Organ Component]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.53: Samples were homogenized (1:10 w/v) with a Dounce homogenizer in an ice-chilled buffer containing 50 mM Hepes, pH7.4, 150 mM NaCl, 5 mM EDTA, 10 M leupeptin, 1 g/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "homogenized"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10 w/v"

Phrase: ")"

Phrase: "with a Dounce homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]

Phrase: "in an ice-chilled buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH7.4,"

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "10 M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "1 mM phenylmethylsulfonyl fluoride."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.54: Homogenates were centrifuged at 3000 x g for 10 min at 4 C, and the supernatants were used for the determination of proteasome peptidase activity and immunoblotting. 

Phrase: "Homogenates"

Phrase: "were"

Phrase: "centrifuged at 3000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C,"

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used for the determination of proteasome peptidase activity"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   770   C1150095:peptidase activity [Molecular Function]
   767   C1622946:proteasome activity [Molecular Function]
   750   C1524063:Use of [Functional Concept]
   744   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1148554:determination [Laboratory Procedure]
   744   C1273517:used [Finding]
   744   C1325620:proteasome [Cell Component]
   744   C1561536:*Activity [Idea or Concept]
   744   C1752727:Proteasome [Molecular Function]
   744   C1947941:Peptidase [Enzyme]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.55: Cells were scraped from plates in phosphate-buffered saline, washed two times in phosphate-buffered saline, and the cell pellets were resuspended in a buffer containing: 50 mM Hepes, pH 7.4, 50 mM NaCl, 5 mM EDTA, 10 M leupeptin, 1 g/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "scraped from plates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0184933:scraped [Therapeutic or Preventive Procedure]
   790   C0444082:scraped [Body Substance]
   790   C1139930:plates [Medical Device]
   756 E C0005971:Plate [Medical Device]
   756 E C3537155:Plate [Manufactured Object]

Phrase: "in phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "two times in phosphate-buffered saline,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C1948050:Two Times [Quantitative Concept]
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C0040223:times [Temporal Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in a buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: ":"

Phrase: "50 mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "10 M leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "1 mM phenylmethylsulfonyl fluoride."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.56: Homogenization was performed either by two cycles of freezing (70 C) and thawing at 37 C or with Dounce homogenizer. 

Phrase: "Homogenization"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "either by two cycles of freezing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0016701:Freezing [Natural Phenomenon or Process]
   753   C0205448:Two [Quantitative Concept]
   719   C1511572:Cycle [Temporal Concept]

Phrase: "(70 C)"

Phrase: "and"

Phrase: "thawing at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710378:Thaw [Laboratory Procedure]

Phrase: "or with Dounce homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.57: Cell homogenates were centrifuged at 3000 x g for 10 min at 4 C, and the supernatants were used for determination of proteasome peptidase activity and immunoblotting. 

Phrase: "Cell homogenates"

Phrase: "were"

Phrase: "centrifuged at 3000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C,"

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used for determination of proteasome peptidase activity"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   778   C1150095:peptidase activity [Molecular Function]
   774   C1622946:proteasome activity [Molecular Function]
   757   C1524063:Use of [Functional Concept]
   748   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1148554:determination [Laboratory Procedure]
   748   C1273517:used [Finding]
   748   C1325620:proteasome [Cell Component]
   748   C1561536:*Activity [Idea or Concept]
   748   C1752727:Proteasome [Molecular Function]
   748   C1947941:Peptidase [Enzyme]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.58: Peptidase activities were determined with synthetic fluorogenic peptides (N-Suc-LLVY-MCA, Z-LLE-MCA, and Boc-LRR-MCA) in a Fluorskan microplate reader (excitation, 380 nm; emission, 460 nm) as described (37). 

Phrase: "Peptidase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150095:peptidase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined with synthetic fluorogenic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C1883254:synthetic [Activity]

Phrase: "(N-Suc-LLVY-MCA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0143954:Suc-LLVY-MCA [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
           LLVY-MCA
   812   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "Z-LLE-MCA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Boc-LRR-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517773:LRR [Amino Acid Sequence]

Phrase: "MCA) in a Fluorskan microplate reader"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "(excitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "380 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "; emission,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233929:Emission [Body Substance]
  1000   C2349995:Emission [Substance]

Phrase: "460 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.59: The reaction mixture contains in a final volume of 200 l of 20 mM Hepes, pH 7.4, 50 M indicated peptide, and different amounts of the corresponding brain or cell extract to be assayed. 

Phrase: "The reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "contains in a final volume of 200 l of 20 mM Hepes,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   736   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   736   C0205088:Final [Temporal Concept]
   736   C0332256:contain [Functional Concept]
   736   C0449468:*Volume [Quantitative Concept]
   736   C1546485:Final [Idea or Concept]
   736   C1690016:% volume [Qualitative Concept]
   736   C1705102:Volume [Intellectual Product]
   736   C2700258:Volume [Laboratory Procedure]
   736   C2700400:Contain [Activity]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "different amounts of the corresponding brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "or"

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.60: Assays were kinetically followed for 1 h, and the reaction rates were linear with respect to time and the amount of protein extract (520 g of protein). 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "kinetically"

Phrase: "followed for 1 h,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332283:followed [Temporal Concept]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "the reaction rates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0678608:reaction rate [Temporal Concept]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "linear with respect to time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205132:Linear [Spatial Concept]

Phrase: "and"

Phrase: "the amount of protein extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(520 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.61: Parallel reactions containing either 25 M MG132 or 10 M Lacatacystin were run as controls. 

Phrase: "Parallel reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either 25 M MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "10 M Lacatacystin"

Phrase: "were"

Phrase: "run as controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0035953:run [Daily or Recreational Activity]
   790   C0600140:run [Finding]
   790   C1704688:Run [Functional Concept]
   790   C2346414:Run [Finding]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.62: The values reported for proteasome peptidase activities are expressed as relative fluorescence arbitrary units/min/mg of total protein  S.D. after subtraction for nonspecific peptide hydrolysis (control reactions). 

Phrase: "The values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "reported for proteasome peptidase activities"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   790   C1150095:peptidase activity [Molecular Function]
   781   C1622946:proteasome activity [Molecular Function]
   760   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0441655:Activities [Activity]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1325620:proteasome [Cell Component]
   760   C1752727:Proteasome [Molecular Function]
   760   C1947941:Peptidase [Enzyme]
   760   C3496591:Reported [Clinical Attribute]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]
   726 E C3273238:Report [Intellectual Product]

Phrase: "are"

Phrase: "expressed as relative fluorescence arbitrary units/min/mg"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   793   C2699026:Relative Fluorescence Units [Quantitative Concept]
   789   C2698180:Arbitrary Fluorescence Units [Quantitative Concept]
   767   C0439420:mg/min [Quantitative Concept]
   767   C2348686:Fluorescence Units [Quantitative Concept]
   754   C1532693:Unit/min [Temporal Concept]
   750   C1638407:Unit/mg [Quantitative Concept]
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C0439148:Units [Quantitative Concept]
   744   C0439269:mg% [Quantitative Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1264693:*Arbitrary [Quantitative Concept]
   744   C1519795:Units [Quantitative Concept]
   744   C1547039:*Relative [Quantitative Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   737   C0439183:Arbitrary unit [Quantitative Concept]
   711 E C1704753:Unit [Manufactured Object]
   711 E C1880519:Unit [Quantitative Concept]

Phrase: "of total protein  S.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418948:PROTEIN S [Gene or Genome]

Phrase: "after subtraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348589:Subtraction [Phenomenon or Process]

Phrase: "for nonspecific peptide hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "(control reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.63: For immunoblot analysis, 20 g of total protein was loaded onto 12% SDS-PAGE, transferred to nitrocellulose, and immunoblotted with different antibodies. 

Phrase: "For immunoblot analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "20 g of total protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "loaded onto 12% SDS-PAGE,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1704732:Page [Intellectual Product]
   760   C1708715:Loaded [Activity]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted with different antibodies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C1705242:Different [Qualitative Concept]
   737   C0020985:Immunoblot [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.64: Developing was performed with peroxidase-labeled goat anti-mouse, or anti-rabbit antibodies, at 1/4000 dilution by chemiluminescence method. 

Phrase: "Developing"

Phrase: "was"

Phrase: "performed with peroxidase-labeled goat"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0018019:goat [Mammal]
   760   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0884358:Performed [Functional Concept]
   760   C1265549:goat [Mammal]
   760   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   760   C1510458:Goat [Mammal]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "anti-mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "or"

Phrase: "anti-rabbit antibodies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0034493:Rabbit [Mammal]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at 1/4000 dilution by chemiluminescence method."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079240:Dilution [Laboratory Procedure]
   748   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.65: Anti-EYFP monoclonal antibodies were obtained from BD Biosciences (clone JL-8) and used at 1/2500 dilution. 

Phrase: "Anti-EYFP monoclonal antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0746619:monoclonal [Finding]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from BD Biosciences"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(clone JL-8"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "at 1/2500 dilution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0079240:Dilution [Laboratory Procedure]
   812   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.66: Anti-synuclein was detected with either rabbit polyclonal (1/500) or mouse monoclonal antibodies (1/2000, Transduction Laboratories, clone 42). 

Phrase: "Anti-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected with either rabbit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034493:Rabbit [Mammal]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "polyclonal"

Phrase: "(1/500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "mouse monoclonal antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0746619:monoclonal [Finding]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1/2000,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "Transduction Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "clone 42"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: ")."
Processing 00000000.tx.67: Anti-Ib was used at 1/500 dilution. 

Phrase: "Anti-Ib"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "at 1/500 dilution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0079240:Dilution [Laboratory Procedure]
   812   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.68: Anti-C2 (6, 1/1000), anti-C5 (6, 1/1000), anti-C8 (7, 1/1000), and C9 (3, 1/500) have been described previously (33, 36, 36). 

Phrase: "Anti-C2 (6,"

Phrase: "1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "anti-C5 (6,"

Phrase: "1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "anti-C8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305854:C8 [Body Location or Region]

Phrase: "(7,"

Phrase: "1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "C9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413029:C9 [Gene or Genome]
  1000   C3540507:C9 [Gene or Genome]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "1/500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33,"

Phrase: "36,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.69: Anti-LMP2 (i1, 1/500), LMP7 (i5, 1/1000), MECL1 (i2, 1/1000), PA28 (1/1000), PA28 (1/1000), TBP7, and PSMC4 (1/500) were from Affiniti. 

Phrase: "Anti-LMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419019:LMP2 [Gene or Genome]
   861   C2347436:LMP2 [Gene or Genome]

Phrase: "(i1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418824:I1 [Gene or Genome]

Phrase: "1/500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "LMP7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419018:LMP7 [Gene or Genome]

Phrase: "(i5,"

Phrase: "1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "MECL1"

Phrase: "(i2,"

Phrase: "1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "PA28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1166811:PA28 [Cell Component]

Phrase: "(1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "PA28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1166811:PA28 [Cell Component]

Phrase: "(1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "TBP7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419024:TBP7 [Gene or Genome]

Phrase: "and"

Phrase: "PSMC4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419024:PSMC4 [Gene or Genome]

Phrase: "(1/500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "were from Affiniti."
Processing 00000000.tx.70: Anti-Y (1, 1/1000) and anti-Z (2, 1/1000) were from Abcam. 

Phrase: "Anti-Y (1,"

Phrase: "1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "anti-Z (2,"

Phrase: "1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "were from Abcam."
Processing 00000000.tx.71: Anti-ubiquitin (1/1000) antibodies were from Dako. 

Phrase: "Anti-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1/1000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Dako."
Processing 00000000.tx.72: We also used anti-LMP2 and anti-PA28 rabbit polyclonal antibody made by us in rabbits and affinity-purified against recombinant LMP2 and PA28 as described (33). 

Phrase: "We also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-LMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419019:LMP2 [Gene or Genome]
   861   C2347436:LMP2 [Gene or Genome]

Phrase: "and"

Phrase: "anti-PA28 rabbit polyclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "made by us"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1881534:Make [Functional Concept]

Phrase: "in rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "and"

Phrase: "affinity-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified against recombinant LMP2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1419019:LMP2 [Gene or Genome]
   770   C1514798:recombinant [Organism]
   770   C1998793:Purified [Functional Concept]
   770   C2347436:LMP2 [Gene or Genome]

Phrase: "and"

Phrase: "PA28 as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1166811:PA28 [Cell Component]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.73: As control for normalization we used antibodies against -tubulin (Sigma, clone DM 1a) or anti-protein disulfide isomerase antibodies that have been previously fully characterized (38). 

Phrase: "As control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "for normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies against -tubulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "clone DM 1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "or"

Phrase: "anti-protein disulfide isomerase antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   897   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   881 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0072354:Protein Disulfide Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1150347:protein disulfide-isomerase [Molecular Function]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "previously fully"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.74: Quantification was performed by densitometric scan of the respective immunoblots by use of Quantity One software from Bio-Rad. 

Phrase: "Quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "was"

Phrase: "performed by densitometric scan of the respective immunoblots"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0011321:densitometric scan [Laboratory Procedure]
   770   C1550369:Performed By [Qualitative Concept]
   744   C0034606:Scan [Diagnostic Procedure]
   744   C0441633:Scan [Diagnostic Procedure]
   744   C0884358:Performed [Functional Concept]
   744   C2826292:SCAN [Finding]
   711   C0020985:Immunoblot [Laboratory Procedure]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of Quantity One software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "from Bio-Rad."
Processing 00000000.tx.75: Values are expressed as arbitrary densitometric units  S.D. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as arbitrary densitometric units  S.D."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   757   C0439183:Arbitrary unit [Quantitative Concept]
   748   C0439148:Units [Quantitative Concept]
   748   C1264693:*Arbitrary [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.76: Statistical AnalysisResults are expressed as the mean  S.D. 

Phrase: "Statistical AnalysisResults"

Phrase: "are"

Phrase: "expressed as the mean  S.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.77: They were analyzed statistically by the t test between two groups and analysis of variance among multiple groups. 

Phrase: "They"

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "statistically by the t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038215:Statistically [Occupation or Discipline]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]

Phrase: "between two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "analysis of variance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "among multiple groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.78: Statistical significance was accepted at the p < 0.05 level.  

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "accepted at the p < 0.05 level."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1547707:Level [Geographic Area]
   748   C1548435:Accepted [Idea or Concept]
   748   C2946261:Level [Pharmacologic Substance]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.79: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Synuclein Expression in Wild Type, Knock-out, and Transgenic MiceWe first analyzed the expression of -syn in brains obtained from wild type, knock-out, and transgenic mice. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Synuclein Expression in Wild Type, Knock-out,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Transgenic MiceWe"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the expression of -syn in brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "obtained from wild type, knock-out,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0560617:knock out [Injury or Poisoning]
   790   C1522225:Knock-out [Experimental Model of Disease]
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0439787:Out [Spatial Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C0849355:Out [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.80: Results presented in Fig. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.81: 1 show, both in striatum and ventral midbrain (substantia nigra and ventral tegmental area), the complete absence of synuclein in knock-out mice (as expected) and a 15-fold increase in the amount of -syn in transgenic mice for human A30P -syn under the control of PrP promoter (wide expression in all brain areas). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "both in striatum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010097:Striatum [Body Part, Organ, or Organ Component]
   790   C0162512:Striatum [Body Part, Organ, or Organ Component]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "the complete absence of synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in knock-out mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0560617:knock out [Injury or Poisoning]
   734   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "("

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a 15-fold increase in the amount of -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "for human A30P -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of PrP promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(wide expression in all brain areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.82: Similar results were obtained when an analysis was performed with whole brain, cortex, and cerebellum form the different mice under study and in agreement with previous reports describing those mice (34, 35). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "an analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed with whole brain,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0444667:Whole [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the different mice under study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "and in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1515981:And [Idea or Concept]

Phrase: "with previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "describing"

Phrase: "those mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.83: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.84: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.85: -Syn expression in wild type, KO, and transgenic mice for -syn. 

Phrase: "-Syn expression in wild type, KO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "transgenic mice for -syn."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
Processing 00000000.tx.86: Brain samples from the striatum and ventral midbrain (substantia nigra and ventral tegmental area) were processed for Western and immunoblot, as described under "Materials and Methods" with polyclonal anti-synuclein antibodies. 

Phrase: "Brain samples from the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "were"

Phrase: "processed for Western"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1522240:Processed [Phenomenon or Process]
   790   C1705493:Western [Spatial Concept]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "immunoblot,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "with polyclonal anti-synuclein antibodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   886   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.87: Left panels show representative immunoblots from the different mice under study, KO, hsyn A30P transgenic, and their respective controls labeled wild type (WT) and TG-. 

Phrase: "Left panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "representative immunoblots from the different mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "under study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "KO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "hsyn A30P"

Phrase: "transgenic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "their respective controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "wild type (WT)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "TG-."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337445:TG [Laboratory Procedure]
Processing 00000000.tx.88: The right panels show the quantitation of the immunoblots expressed in arbitrary densitometric units  S.D. for n = 3 different animals, each one assayed by duplicate.  

Phrase: "The right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the quantitation of the immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "expressed in arbitrary densitometric units  S.D."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   757   C0439183:Arbitrary unit [Quantitative Concept]
   748   C0439148:Units [Quantitative Concept]
   748   C1264693:*Arbitrary [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]

Phrase: "for n = 3 different animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "each one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "assayed by duplicate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205173:Duplicate [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.89: Proteasome Activity and Expression in Wild Type, Knock-out and Transgenic MiceIf the hypothesis that the levels -syn expression somehow modify proteasome peptidase activity, we were in good condition to test this hypothesis in the mice under study with zero (knock-out), normal levels (wt), or high levels (15-fold, human synA30P transgenic). 

Phrase: "Proteasome Activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Expression in Wild Type, Knock-out"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Transgenic MiceIf"

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the levels -syn expression somehow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "proteasome peptidase activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1622946:proteasome activity [Molecular Function]
   901   C1150095:peptidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "were in good condition to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012634:condition [Disease or Syndrome]
   760   C0205170:Good [Qualitative Concept]
   760   C0348080:Condition [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis in the mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512571:Hypothesis [Idea or Concept]

Phrase: "under study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "with zero"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919414:Zero [Quantitative Concept]

Phrase: "(knock-out"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0560617:knock out [Injury or Poisoning]
  1000   C1522225:Knock-out [Experimental Model of Disease]
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "normal levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(wt),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "or"

Phrase: "high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(15-fold, human synA30P"

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: ")."
Processing 00000000.tx.90: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.91: 2, the three peptidase activities of the proteasome in the striatum and in the ventral midbrain do not significantly change between KO and wt or between transgenic and not transgenic mice. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "the three peptidase activities of the proteasome"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C1150095:peptidase activity [Molecular Function]
   757   C1622946:proteasome activity [Molecular Function]
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "in the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "and in the ventral midbrain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   760   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C1704448:Ventral [Spatial Concept]

Phrase: "do"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "change between KO"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C1416746:KO [Gene or Genome]
   790   C1705241:Change [Quantitative Concept]
   790   C1862225:Ko [Body System]

Phrase: "and"

Phrase: "wt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "or between transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "not transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.92: We also found no difference in proteasome peptidase activity in whole brain, cortex, and cerebellum extracts from similar mice (data not shown). 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no difference in proteasome peptidase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "in whole brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "extracts from similar mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C2348205:Similar [Qualitative Concept]
   770   C2828366:Extract [Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.93: The results obtained with brain samples from the human syn A30P transgenic mice are not significantly affected by the gliosis that eventually developed in these animals, as we used heterozygous 4-month-old animals where no clear gliosis can be found (35), and we observed no change in the expression of glial fibrillary acidic protein between control and synA30P transgenic mice by immunoblot analysis (data not shown). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained with brain samples"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   802   C1277697:Sample obtained [Finding]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1301820:Obtained [Functional Concept]
   737   C0370003:Sample [Substance]
   737 E C1706701:Obtain [Activity]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from the human syn A30P transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affected by the gliosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017639:Gliosis [Pathologic Function]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "that eventually"

Phrase: "developed in these animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003062:Animals [Animal]

Phrase: "as"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "heterozygous 4-month-old animals where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0003062:Animals [Animal]

Phrase: "no clear gliosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017639:Gliosis [Pathologic Function]

Phrase: "can"

Phrase: "be"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "no change in the expression of glial fibrillary acidic protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442739:No change [Finding]
   760   C1548568:No change [Intellectual Product]
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]

Phrase: "between control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "synA30P transgenic mice by immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: These results clearly indicate that there is no correlation between the level of expression of -syn and proteasome peptidase activity in mice. 

Phrase: "These results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that there"

Phrase: "is"

Phrase: "no correlation between the level of expression of -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "proteasome peptidase activity in mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1150095:peptidase activity [Molecular Function]
   797   C1622946:proteasome activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.95: Nevertheless, we found that the peptidase activity of the proteasome (mainly the chymotrypsin-like activity) in ventral midbrain (substantia nigra and ventral tegmental area) is 5070% (analysis of variance, p < 0.05) of the activity observed in striatum. 

Phrase: "Nevertheless,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the peptidase activity of the proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1150095:peptidase activity [Molecular Function]
   783   C1622946:proteasome activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(mainly"

Phrase: "the chymotrypsin-like activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1150252:chymotrypsin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1413809:chymotrypsin-like [Gene or Genome]

Phrase: ")"

Phrase: "in ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "is"

Phrase: "5070%"

Phrase: "(analysis of variance,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "of the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "observed in striatum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010097:Striatum [Body Part, Organ, or Organ Component]
   790   C0162512:Striatum [Body Part, Organ, or Organ Component]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.96: This difference is observed for all type of mice used in this study. 

Phrase: "This difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "is"

Phrase: "observed for all type of mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0332307:Type [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.97: This reduction of proteasome activity could be attributed to a regional brain difference in proteasome expression (see below), or to the presence of a proteasome "activator" in the striatum, or an "inhibitor" in the ventral midbrain. 

Phrase: "This reduction of proteasome activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "be"

Phrase: "attributed to a regional brain difference"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0682132:regional difference [Finding]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0205147:regional [Spatial Concept]
   753   C0205276:Regional [Spatial Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]
   753   C1947913:Regional [Spatial Concept]
   719   C0449234:Attribute [Idea or Concept]
   719   C1704772:Attribute [Conceptual Entity]
   719   C1882133:Attribute [Qualitative Concept]

Phrase: "in proteasome expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "or to the presence of a proteasome ""activator"""
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1325620:proteasome [Cell Component]
   744   C1752727:Proteasome [Molecular Function]

Phrase: "in the striatum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "an ""inhibitor"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "in the ventral midbrain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]
Processing 00000000.tx.98: To test the last possibilities, we performed proteasome peptidase assays with a fixed amount of striatum extract and increasing amounts (up to 4-fold) of the ventral midbrain extract and vice versa. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the last possibilities,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C0332149:Possible [Qualitative Concept]
   777   C1705910:Possible [Qualitative Concept]
   777   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "proteasome peptidase assays with a fixed amount of striatum extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0005507:Assay [Laboratory Procedure]
   706   C0243073:assay [Qualitative Concept]
   706   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "increasing amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "("

Phrase: "up to 4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "of the ventral midbrain extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "vice versa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]
Processing 00000000.tx.99: These experiments show additive results; 

Phrase: "These experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "additive results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ";"
Processing 00000000.tx.100: the activity of the mix was equal to the sum of activities of the two extracts assayed independently (data not shown), clearly discarding the presence of an "activator" or "inhibitor" of the proteasome in the striatum and ventral midbrain, respectively. 

Phrase: "the activity of the mix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "equal to the sum of activities of the two extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205163:Equal To [Qualitative Concept]
           Equal
   739   C1549782:Equal [Idea or Concept]

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "independently"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "clearly"

Phrase: "discarding"

Phrase: "the presence of an ""activator"" or ""inhibitor"" of the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral midbrain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.101: View larger version (39K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.103: Proteasome peptidase activities in wild type, KO (-syn), and transgenic mice (hsyn A30P). 

Phrase: "Proteasome peptidase activities in wild type, KO (-syn"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   754   C1150095:peptidase activity [Molecular Function]
   750   C1622946:proteasome activity [Molecular Function]
   744   C0441655:Activities [Activity]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(hsyn A30P"

Phrase: ")."
Processing 00000000.tx.104: Proteasome peptidase activities were assayed in brain samples from striatum and ventral midbrain (substantia nigra and ventral tegmental area) using model fluorogenic peptides N-Suc-LLVY-MCA, N-Suc-LLE-MCA, and LRR-MCA for assaying the chymotrypsin, postglutamyl-peptidyl-hydrolase, and trypsin-like activities as described under "Material and Methods." 

Phrase: "Proteasome peptidase activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C1622946:proteasome activity [Molecular Function]
   884   C1150095:peptidase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "assayed in brain samples"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C0370003:Sample [Substance]
   737   C1510438:Assay [Laboratory Procedure]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "model fluorogenic peptides N-Suc-LLVY-MCA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0143954:Suc-LLVY-MCA [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
           LLVY-MCA
   795   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "N-Suc-LLE-MCA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "LRR-MCA for assaying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "the chymotrypsin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "postglutamyl-peptidyl-hydrolase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020289:Hydrolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "trypsin-like activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   896   C1150284:trypsin activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "described under ""Material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Material [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.105: Values are expressed as fluorescence (arbitrary units)/min/mg total protein  S.D. for n = 3 different animals, each one assayed by triplicate.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0016315:Fluorescence [Natural Phenomenon or Process]
   718 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: "/min/mg total protein  S.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0439423:mg/d [Quantitative Concept]
   858   C2827883:mg/s [Quantitative Concept]
   827   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418948:PROTEIN S [Gene or Genome]

Phrase: "for n = 3 different animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "each one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "assayed by triplicate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205174:Triplicate [Quantitative Concept]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.106: Then we analyzed the level of expression of proteasome subunits in the same brain regions. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the level of expression of proteasome subunits"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3244092:expression level [Idea or Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in the same brain regions."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.107: We explored the expression of proteasome , constitutive , and -interferon-inducible subunits. 

Phrase: "We"

Phrase: "explored"

Phrase: "the expression of proteasome ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constitutive ,"

Phrase: "and -"

Phrase: "interferon-inducible subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.108: Representative immunoblots of these experiments are presented in Fig. 

Phrase: "Representative immunoblots of these experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.109: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.110: The quantitation of these experiments shows very little change in the level of expression of proteasomal (C2, 6; C8, 7; C9, 3), (C5, 6; Y,1; Z, 2) and -inducible subunits (LMP2, 1i; LMP7, 5i; MECL-1, 2i) between control, KO, and transgenic animals for the same brain area. 

Phrase: "The quantitation of these experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "very little change in the level of expression of proteasomal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]

Phrase: "(C2,"

Phrase: "6"

Phrase: "; C8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305854:C8 [Body Location or Region]

Phrase: "7"

Phrase: "; C9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413029:C9 [Gene or Genome]
  1000   C3540507:C9 [Gene or Genome]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "(C5,"

Phrase: "6"

Phrase: "; Y,1"

Phrase: "; Z,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and -"

Phrase: "inducible subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "(LMP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419019:LMP2 [Gene or Genome]
  1000   C2347436:LMP2 [Gene or Genome]

Phrase: "1i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552165:1i [Medical Device]

Phrase: "; LMP7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419018:LMP7 [Gene or Genome]

Phrase: "5i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552169:5i [Medical Device]

Phrase: "; MECL-1,"

Phrase: "2i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552166:2i [Medical Device]

Phrase: ")"

Phrase: "between control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "KO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "and"

Phrase: "transgenic animals for the same brain area."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0003069:Animals, Transgenic [Animal]
   748   C0003062:Animals [Animal]
Processing 00000000.tx.111: We also analyzed the levels of expression of proteasome activator PA28 in the same brain regions (Fig. 4), PA28 (almost undetectable levels, data not shown), and a component of the 19 S proteasomal regulator TBP7 (PSMC4, data not shown), and found again no differences between control, KO, and transgenic mice. 

Phrase: "We also"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the levels of expression of proteasome activator PA28"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C3244092:expression level [Idea or Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the same brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C1273723:brain regions [Body Location or Region]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "PA28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1166811:PA28 [Cell Component]

Phrase: "(almost undetectable levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a component of the 19 S proteasomal regulator TBP7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "(PSMC4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419024:PSMC4 [Gene or Genome]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "again"

Phrase: "no differences between control,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "KO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "and"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.112: Collectively these data clearly demonstrate the lack of correlation between -syn expression levels and proteasome subunit expression. 

Phrase: "Collectively"

Phrase: "these data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "the lack of correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "between -syn expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "proteasome subunit expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.113: When the overall proteasome subunit expression levels were compared between striatum and ventral midbrain (substantia nigra and ventral tegmental area), there is a small (but significant) decrease in the amount of proteasome subunits in the ventral midbrain respect to striatum (2025%, analysis of variance, p < 0.05). 

Phrase: "When"

Phrase: "the overall proteasome subunit expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C3244092:expression level [Idea or Concept]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "compared between striatum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010097:Striatum [Body Part, Organ, or Organ Component]
   790   C0162512:Striatum [Body Part, Organ, or Organ Component]
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "is"

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "("

Phrase: "but"

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: ")"

Phrase: "decrease in the amount of proteasome subunits"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C1325620:proteasome [Cell Component]
   748   C1752727:Proteasome [Molecular Function]
   714   C1711351:Subunit [Quantitative Concept]

Phrase: "in the ventral midbrain respect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679133:respect [Social Behavior]

Phrase: "to striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "(2025%,"

Phrase: "analysis of variance,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.114: This small decrease in level of expression may account for the lower proteasome peptidase activity observed in the midbrain region with respect to the striatum. 

Phrase: "This small decrease in level of expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "may"

Phrase: "account for the lower proteasome peptidase activity"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   778   C1150095:peptidase activity [Molecular Function]
   774   C1622946:proteasome activity [Molecular Function]
   748   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0441994:Lower [Spatial Concept]
   748   C1325620:proteasome [Cell Component]
   748   C1548802:Lower [Body Location or Region]
   748   C1551359:account [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1752727:Proteasome [Molecular Function]
   748   C1947941:Peptidase [Enzyme]
   748   C2003888:Lower [Activity]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]

Phrase: "observed in the midbrain region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017446:Region [Geographic Area]
   760   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   760   C0205147:Region [Spatial Concept]
   760   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]

Phrase: "with respect to the striatum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.115: View larger version (68K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(68K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.116: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.117: Proteasome subunit expression levels in wild type, KO (-syn), and transgenic mice (hsyn A30P). 

Phrase: "Proteasome subunit expression levels in wild type, KO (-syn"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0441889:Levels [Qualitative Concept]
   731   C3244092:expression level [Idea or Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(hsyn A30P"

Phrase: ")."
Processing 00000000.tx.118: Samples from striatum and ventral midbrain (substantia nigra and ventral tegmental area) from different animals (representative blots are presented) were analyzed by Western immunoblotting with different proteasomal subunits, as indicated. 

Phrase: "Samples from striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "from different animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(representative blots"

Phrase: "are"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by Western immunoblotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Immunoblotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Immunoblot [Laboratory Procedure]
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with different proteasomal subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.119: Quantitation was done by densitometric scanning, as described under "Materials and Methods," using anti-tubulin or anti-protein-disulfide isomerase antibodies as controls for protein loading (not shown).  

Phrase: "Quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "done by densitometric scanning,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0011321:densitometric scanning [Laboratory Procedure]
   770   C0034606:Scanning [Diagnostic Procedure]
   770   C0441633:Scanning [Diagnostic Procedure]
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: """"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "or"

Phrase: "anti-protein-disulfide isomerase antibodies as controls"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   774   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for protein loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: View larger version (54K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.121: 4. 

Phrase: "4."
Processing 00000000.tx.122: PA28 expression levels in wild type, KO (-syn), and transgenic mice (hsyn A30P). 

Phrase: "PA28 expression levels in wild type, KO (-syn"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(hsyn A30P"

Phrase: ")."
Processing 00000000.tx.123: Samples from the striatum and ventral midbrain (substantia nigra and ventral tegmental area) from different animals (representative blots are presented) were analyzed by Western immunoblotting with antibodies against PA28 . Quantitation was done by densitometric scanning, as described under "Materials and Methods," using anti-tubulin antibodies as controls for protein loading.  

Phrase: "Samples from the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "from different animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(representative blots"

Phrase: "are"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by Western immunoblotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Immunoblotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Immunoblot [Laboratory Procedure]
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against PA28 . Quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "done by densitometric scanning,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0011321:densitometric scanning [Laboratory Procedure]
   770   C0034606:Scanning [Diagnostic Procedure]
   770   C0441633:Scanning [Diagnostic Procedure]
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: """"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-tubulin antibodies as controls"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for protein loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.124: Proteasome Activity and Expression in PC12 Cells and Stable PC12 Transfectants with EYFP, EYFPsyn wt, EYFPsyn A30P, and EYFPsyn A53TNext we investigated proteasome peptidase activities and subunit expression in PC12 cell lines transfected with EYFP--synucleins and their respective controls. 

Phrase: "Proteasome Activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Expression in PC12 Cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Stable PC12 Transfectants with EYFP,"

Phrase: "EYFPsyn wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "EYFPsyn A30P,"

Phrase: "and"

Phrase: "EYFPsyn A53TNext"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "proteasome peptidase activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C1622946:proteasome activity [Molecular Function]
   884   C1150095:peptidase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "subunit expression in PC12 cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "transfected with EYFP"

Phrase: "--"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their respective controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.125: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.126: 5A shows the results of immunoblots of the different cell lines generated with anti-synuclein antibodies. 

Phrase: "5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553637:5a [Medical Device]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the results of immunoblots of the different cell lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "generated with anti-synuclein antibodies."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C3146294:Generated [Activity]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.127: Although endogenous -syn was expressed in all cell lines, transfected cell lines clearly overexpressed 1020-fold higher levels of the EYFP--syn fusion proteins (Fig. 5A, right panel). 

Phrase: "Although"

Phrase: "endogenous -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "expressed in all cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "transfected cell lines clearly"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "1020-fold higher levels of the EYFP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "--syn fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.128: The measurement of proteasome peptidase activities in crude extracts and immunoblots with anti-, constitutive , and inducible subunits are shown in Fig. 

Phrase: "The measurement of proteasome peptidase activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:Measurement [Functional Concept]

Phrase: "in crude extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1258023:Crude Extracts [Chemical]
   827   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "immunoblots with anti-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "constitutive ,"

Phrase: "and"

Phrase: "inducible subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.129: 4, B and C, respectively. 

Phrase: "4,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "respectively."
Processing 00000000.tx.130: Proteasome peptidase activities (Fig. 4B) are not significantly affected by overexpression of EYFP or the EYFP--syn fusion constructs, similarly, the quantification of the immunoblots (Fig. 5C) shows no significant changes in the expression of proteasomal subunits. 

Phrase: "Proteasome peptidase activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C1622946:proteasome activity [Molecular Function]
   884   C1150095:peptidase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: "are"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affected by overexpression of EYFP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1514559:Overexpression [Genetic Function]
   726 E C0001721:Affect [Mental Process]

Phrase: "or"

Phrase: "the EYFP"

Phrase: "--syn fusion constructs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C2827421:Construct [Classification]

Phrase: "similarly,"

Phrase: "the quantification of the immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "(Fig. 5C"

Phrase: ")"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no significant changes in the expression of proteasomal subunits."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   745   C0442739:No change [Finding]
   745   C1548568:No change [Intellectual Product]
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.131: Furthermore proteasome activator PA28 , PA28 (expressed at very low levels in PC12) cells, and TBP7, PSMC4, also did not significantly change (data not shown). 

Phrase: "Furthermore proteasome activator PA28 ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1166811:PA28 [Cell Component]

Phrase: "PA28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1166811:PA28 [Cell Component]

Phrase: "("

Phrase: "expressed at very low levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0442811:Very low [Finding]
   760   C0205251:low [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "TBP7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419024:TBP7 [Gene or Genome]

Phrase: "PSMC4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419024:PSMC4 [Gene or Genome]

Phrase: "also"

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: View larger version (60K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(60K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.134: Proteasome peptidase activities and subunit expression in control and stably transfected PC12 cells. 

Phrase: "Proteasome peptidase activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C1622946:proteasome activity [Molecular Function]
   884   C1150095:peptidase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "subunit expression in control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "stably transfected PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: A, immunoblot analysis with anti-synuclein antibodies of PC12 untransfected and stably transfected with EYFP, EYFP-syn wt, EYFP-syn A30P, and EYFP-syn A53T. 

Phrase: "A,"

Phrase: "immunoblot analysis with anti-synuclein antibodies of PC12 untransfected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "stably"

Phrase: "transfected with EYFP,"

Phrase: "EYFP-syn wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2700323:WT [Fish]

Phrase: "EYFP-syn A30P,"

Phrase: "and"

Phrase: "EYFP-syn A53T."
Processing 00000000.tx.136: The graph shows the quantitation in arbitrary densitometric units  S.D. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the quantitation in arbitrary densitometric units  S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709793:Quantitation [Quantitative Concept]
Processing 00000000.tx.137: (n = 3). 

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: B, representation of the proteasome peptidase activities of the different cells lines assayed with synthetic fluorogenic peptides as indicated, results are the average  S.D. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "representation of the proteasome peptidase activities of the different cells lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1514861:Representation [Conceptual Entity]
   738   C1882932:Representation [Activity]

Phrase: "assayed with synthetic fluorogenic peptides"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C1883254:synthetic [Activity]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the average  S.D."
Processing 00000000.tx.139: (n = 3) run in triplicate. 

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "run in triplicate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205174:Triplicate [Quantitative Concept]
   734   C3274438:RUN-IN [Temporal Concept]
Processing 00000000.tx.140: C, representative immunoblots of total cell extracts obtained from the different PC12 cells lines analyzed with antibodies to the indicated proteasomal subunits. 

Phrase: "C,"

Phrase: "representative immunoblots of total cell extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "obtained from the different PC12 cells lines"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   778   C0007600:cells lines [Cell]
   778   C0085262:PC12 Cells [Cell]
           PC-12
   748   C0007634:Cells [Cell]
   748   C0205132:lines [Spatial Concept]
   748   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   748   C1301820:Obtained [Functional Concept]
   748   C1705242:Different [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1706701:Obtain [Activity]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "analyzed with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0936012:Analyzed [Research Activity]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to the indicated proteasomal subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.141: For detailed description see "Materials and Methods." 

Phrase: "For detailed description see ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.142: Quantitation was done by densitometric scanning using anti-tubulin antibodies as controls for protein loading.  

Phrase: "Quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "done by densitometric scanning"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0011321:densitometric scanning [Laboratory Procedure]
   770   C0034606:Scanning [Diagnostic Procedure]
   770   C0441633:Scanning [Diagnostic Procedure]
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-tubulin antibodies as controls"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for protein loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.143: Proteasome Assembly in PC12-transfected Cell LinesAs mentioned in the Introduction, it has been reported that in the substantia nigra of PD patients there is a decrease of proteasomal -subunits expression with little change of subunits (25). 

Phrase: "Proteasome Assembly in PC12-transfected Cell LinesAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1523886:proteasome assembly [Molecular Function]
   774   C0598084:cell assembly [Cell Function]
   748   C1706853:Assembly [Activity]
   748   C1879748:Assembly [Manufactured Object]

Phrase: "mentioned in the Introduction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1293116:Introduction [Health Care Activity]
   770   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that in the substantia nigra of PD patients there"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0030567:Parkinson Disease [Disease or Syndrome]
   760   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   760   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   760   C1521736:Parkinson's Disease [Functional Concept]
   760   C2681933:PARKINSON DISEASE [Gene or Genome]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0030705:Patients [Patient or Disabled Group]

Phrase: "is"

Phrase: "a decrease of proteasomal -subunits expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "with little change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "of subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1711351:Subunit [Quantitative Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.144: One possibility to explain these results is that -syn may alter the assembly line of the proteasome. 

Phrase: "One possibility to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   755   C0332149:Possible [Qualitative Concept]
   755   C1705910:Possible [Qualitative Concept]
   755   C2362652:Possible [Qualitative Concept]

Phrase: "explain"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "is"

Phrase: "that -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the assembly line of the proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1523886:proteasome assembly [Molecular Function]
   753   C0205132:Line [Spatial Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.145: To test this hypothesis we analyzed the proteasome complex in brains from the different mice strains (wild type, KO, and transgenic) and from the different PC12-transfected cell lines by immunoprecipitation with anti-whole proteasome complex antibodies (36). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the proteasome complex in brains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "from the different mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "(wild type, KO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1416746:KO [Gene or Genome]
   827   C1862225:Ko [Body System]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: ")"

Phrase: "and from the different PC12-transfected cell lines"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0007600:Cell lines [Cell]
   767   C0085262:PC12 Cell [Cell]
           PC-12
   744   C0007634:Cell [Cell]
   744   C0205132:lines [Spatial Concept]
   744   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   744   C1269647:Cell [Cell]
   744   C1515981:And [Idea or Concept]
   744   C1704653:Cell [Medical Device]
   744   C1705242:Different [Qualitative Concept]
   744   C1948049:Cell [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]

Phrase: "by immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with anti-whole proteasome complex antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   897   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   881 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.146: The results obtained demonstrate that the proteasome complex contains both - and -subunits, and that no free - or -subunits remained in the supernatants after immunoprecipitation (data not shown). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the proteasome complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "both -"

Phrase: "and -"

Phrase: "subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "no free - or -subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "remained in the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1550101:Supernatant [Body Substance]

Phrase: "after immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: Furthermore a gel filtration experiment of crude soluble extracts from mouse brains or stably transfected PC12 cells failed to detect any free -or -proteasomal subunit (data not shown). 

Phrase: "Furthermore"

Phrase: "a gel filtration experiment of crude soluble extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0681814:Experiment [Research Activity]
   744   C1706386:Experiment [Conceptual Entity]

Phrase: "from mouse brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "stably transfected PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any free -or -proteasomal subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.148: To study more deeply the possible effect of -syn overexpression in proteasome assembly, we performed pulse-chase experiments in the transfected PC12 cell lines. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "more deeply"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "the possible effect of -syn overexpression in proteasome assembly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514559:Overexpression [Genetic Function]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pulse-chase experiments in the transfected PC12 cell lines."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0681814:Experiments [Research Activity]
   708 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.149: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.150: 6, anti-proteasome antibodies immunoprecipitated proteasome precursors after the pulse, clearly identified by the presence of pre-Z (pre-2) in the immunoprecipitated complex and the association with the immature complex of p17, the homologue of Ump1p (36). 

Phrase: "6,"

Phrase: "anti-proteasome antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "proteasome precursors after the pulse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1709634:Precursor [Idea or Concept]

Phrase: "clearly"

Phrase: "identified by the presence of pre-Z (pre-2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0205396:Identified [Qualitative Concept]
   742   C0332152:Pre [Temporal Concept]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0740175:Pre [Qualitative Concept]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]
   742   C2257086:PRE [Genetic Function]

Phrase: ")"

Phrase: "in the immunoprecipitated complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "the association with the immature complex of p17,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "the homologue of Ump1p"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1334043:Homologue [Gene or Genome]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.151: After 8 h of chase, both in PC12 cells overexpressing EYFP and the fusion EYFP--syn, the mature proteasome is fully assembled with similar kinetics, as denoted by the absence of the -subunit precursor and the p17 chaperon (note also the incorporation of processed LMP2 subunit). 

Phrase: "After 8 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of chase,"

Phrase: "both in PC12 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   770   C0007634:Cells [Cell]
   770   C0238767:Both [Spatial Concept]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C1706086:Both [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "EYFP"

Phrase: "and"

Phrase: "the fusion EYFP"

Phrase: "--syn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the mature proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "fully"

Phrase: "assembled with similar kinetics,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0022702:Kinetics [Natural Phenomenon or Process]
   770   C0220865:kinetics [Functional Concept]
   770   C2348205:Similar [Qualitative Concept]
   770   C2825046:Kinetics [Occupation or Discipline]
   737   C1706853:Assemble [Activity]

Phrase: "as"

Phrase: "denoted by the absence of the -subunit precursor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   744   C1709634:Precursor [Idea or Concept]
   744   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "the p17 chaperon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(note also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1316572:Note [Clinical Attribute]
   861   C1317574:Note [Intellectual Product]
   861   C1369612:Note [Clinical Attribute]

Phrase: "the incorporation of processed LMP2 subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243126:incorporation [Functional Concept]

Phrase: ")."
Processing 00000000.tx.152: These results and similar results obtained with PC12 cell lines transfected with EYFP--syn A30P and A53T, clearly indicated that overexpression of -syn has no significant impact on proteasome complex assembly. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "and"

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "obtained with PC12 cell lines"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0007600:Cell lines [Cell]
   806   C0085262:PC12 Cell [Cell]
           PC-12
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   760   C1269647:Cell [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "transfected with EYFP"

Phrase: "--syn A30P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "A53T,"

Phrase: "clearly"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that overexpression of -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "no significant impact on proteasome complex assembly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.153: View larger version (53K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(53K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.154: 6. 

Phrase: "6."
Processing 00000000.tx.155: Proteasome assembly in transfected PC12 cell lines. 

Phrase: "Proteasome assembly in transfected PC12 cell lines."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1523886:proteasome assembly [Molecular Function]
   774   C0598084:cell assembly [Cell Function]
   748   C1706853:Assembly [Activity]
   748   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.156: The figure shows an autoradiogram of immunoprecipitated proteasome complex from pulse (0 h)-chase (hour indicated) experiments of PC12 transfected with EYFP or EYFP--syn wt. 

Phrase: "The figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an autoradiogram of immunoprecipitated proteasome complex"

Phrase: "from pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0232117:PULSE [Clinical Attribute]
  1000   C0391850:Pulse [Physiologic Function]
  1000   C1947910:Pulse [Phenomenon or Process]
   916 E C0034107:Pulses [Health Care Activity]

Phrase: "(0 h)-chase"

Phrase: "(hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439227:Hour [Temporal Concept]
  1000   C0564385:/hour [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ")"

Phrase: "experiments of PC12"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "transfected with EYFP"

Phrase: "or"

Phrase: "EYFP"

Phrase: "--syn wt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2700323:WT [Fish]
Processing 00000000.tx.157: Lines indicate the precursor of Z subunit (pre-2) and the p17 chaperone, which disappear during the chase, a clear indication of the formation of mature proteasome complex, and LMP2 (1i) that is progressively incorporated upon processing during maturation of the proteasome complex.  

Phrase: "Lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "indicate"

Phrase: "the precursor of Z subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709634:Precursor [Idea or Concept]

Phrase: "(pre-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]

Phrase: ")"

Phrase: "and"

Phrase: "the p17 chaperone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "disappear during the chase,"

Phrase: "a clear indication of the formation of mature proteasome complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392360:indication [Idea or Concept]
   739   C3146298:Indication [Functional Concept]

Phrase: "and"

Phrase: "LMP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419019:LMP2 [Gene or Genome]
  1000   C2347436:LMP2 [Gene or Genome]

Phrase: "(1i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552165:1i [Medical Device]

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "progressively"

Phrase: "incorporated upon processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "during maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678723:Maturation [Organism Function]
  1000   C0870861:maturation [Phenomenon or Process]
  1000   C1254042:Maturation [Physiologic Function]

Phrase: "of the proteasome complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.158: Ib Turnover in PC12 -Syn-transfected Cell LinesTo study the impact of synuclein overexpression on proteasome function in a cellular context, we investigated protein ubiquitylation in the stably transfected PC12 cell lines. 

Phrase: "Ib Turnover in PC12 -Syn-transfected Cell LinesTo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0031227:turnover [Quantitative Concept]
   744   C0243127:turnover [Functional Concept]
   744   C0443331:Turnover [Health Care Activity]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the impact of synuclein overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "on proteasome function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "in a cellular context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449255:Context [Finding]
   861   C0542559:Context [Functional Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "protein ubiquitylation in the stably transfected PC12 cell lines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1519751:protein ubiquitylation [Molecular Function]
           Ubiquitylation
Processing 00000000.tx.159: As judged by immunoblots of total cell proteins with anti-ubiquitin antibodies, we found no increase of ubiquitylated proteins in cells overexpressing the different EYFP-syn constructs, and all of the cell lines responded with an increase in the polyubiquitylated proteins in response to the addition of proteasomal inhibitors (data not shown). 

Phrase: "As"

Phrase: "judged by immunoblots of total cell proteins"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   757   C0439177:Protein.total [Quantitative Concept]
   757   C0555903:Total protein [Laboratory Procedure]
   757   C1261360:total protein [Laboratory or Test Result]
   748   C0007634:Cell [Cell]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C0020985:Immunoblot [Laboratory Procedure]
   714   C0221191:Judge [Professional or Occupational Group]

Phrase: "with anti-ubiquitin antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no increase of ubiquitylated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the different EYFP-syn constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "all of the cell lines"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C0444868:All [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3539085:All [Idea or Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "responded with an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "in the polyubiquitylated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of proteasomal inhibitors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   964   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   964   C2266856:Proteasome Inhibitors [Molecular Function]
   947 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: To gain further insight on the possible functional impairment of the proteasome, we decided to study the turnover of a classical short life protein, Ib, in PC12 cells untransfected, transfected with EYFP, or the fusion constructs EYFP--syn. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "further insight on the possible functional impairment of the proteasome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0233820:Insight [Mental Process]

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the turnover of a classical short life protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597297:Protein Turnover [Molecular Function]
   744   C0031227:turnover [Quantitative Concept]
   744   C0243127:turnover [Functional Concept]
   744   C0443331:Turnover [Health Care Activity]

Phrase: "Ib,"

Phrase: "in PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "untransfected,"

Phrase: "transfected with EYFP,"

Phrase: "or"

Phrase: "the fusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332466:Fusion [Functional Concept]
  1000   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "EYFP"

Phrase: "--syn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.161: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.162: 7A shows immunoblot analysis with anti-Ib antibodies of total cell extracts from the different cell lines under study after treatment of the cells with cycloheximide for the times indicated. 

Phrase: "7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "immunoblot analysis with anti-Ib antibodies of total cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "extracts from the different cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0007600:Cell lines [Cell]
   783   C0007592:Cell Extracts [Cell Component]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1705242:Different [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   753   C2828366:Extract [Substance]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "under study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "for the times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.163: The results obtained demonstrate that EYFP or EYFP--syn (wt, A30P, and A53T) overexpression did not significantly altered the degradation rate of Ib. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "demonstrate"

Phrase: "that EYFP"

Phrase: "or"

Phrase: "EYFP"

Phrase: "--syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "A30P,"

Phrase: "and"

Phrase: "A53T"

Phrase: ")"

Phrase: "overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the degradation rate of Ib."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.164: Furthermore, overexpression of -syn also did not affect the rapid turnover of newly synthesized IB as judged by pulse-chase experiments and shown in Fig. 

Phrase: "Furthermore,"

Phrase: "overexpression of -syn also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the rapid turnover of newly synthesized IB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0031227:turnover [Quantitative Concept]
   748   C0243127:turnover [Functional Concept]
   748   C0443331:Turnover [Health Care Activity]

Phrase: "as"

Phrase: "judged by pulse-chase experiments"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0232117:PULSE [Clinical Attribute]
   760   C0391850:Pulse [Physiologic Function]
   760   C0681814:Experiments [Research Activity]
   760   C1947910:Pulse [Phenomenon or Process]
   726   C0221191:Judge [Professional or Occupational Group]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.165: 7B. 

Phrase: "7B."
Processing 00000000.tx.166: In both sets of experiments the inclusion of 10 M lacatacystin completely prevents Ib degradation. 

Phrase: "In both"

Phrase: "sets of experiments"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "the inclusion of 10 M lacatacystin completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1512693:Inclusion [Qualitative Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "Ib degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.167: View larger version (51K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(51K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.168: 7. 

Phrase: "7."
Processing 00000000.tx.169: Ib turnover in untransfected and stably transfected PC12 cell lines. 

Phrase: "Ib turnover in untransfected"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031227:turnover [Quantitative Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "stably transfected PC12 cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0007600:Cell lines [Cell]
   840   C0085262:PC12 Cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.170: A, immunoblot experiments of total cellular extracts from the different PC12 cells (untransfected or transfected with EYFP, EYFP--syn wild type, A30P, and A53T) that have been treated with cycloheximide for the times indicated. 

Phrase: "A,"

Phrase: "immunoblot experiments of total cellular extracts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "from the different PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(untransfected"

Phrase: "or"

Phrase: "transfected with EYFP,"

Phrase: "EYFP"

Phrase: "--syn wild type, A30P,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1883559:Wild Type [Organism Attribute]
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "A53T"

Phrase: ")"

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "treated with cycloheximide"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "for the times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.171: B, an autoradiogram of immunoprecipitated Ib from pulse (0h)-chase (hour indicated) experiments of PC12 transfected with EYFP or stably transfected with EYFP--syn. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "an autoradiogram of immunoprecipitated Ib"

Phrase: "from pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0232117:PULSE [Clinical Attribute]
  1000   C0391850:Pulse [Physiologic Function]
  1000   C1947910:Pulse [Phenomenon or Process]
   916 E C0034107:Pulses [Health Care Activity]

Phrase: "(0h"

Phrase: ")-"

Phrase: "chase"

Phrase: "(hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439227:Hour [Temporal Concept]
  1000   C0564385:/hour [Quantitative Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ")"

Phrase: "experiments of PC12"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0681814:Experiments [Research Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "transfected with EYFP"

Phrase: "or"

Phrase: "stably"

Phrase: "transfected with EYFP"

Phrase: "--syn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.172: Controls under the same conditions, but treated with lactacystin 10 M, are also shown.   

Phrase: "Controls under the same conditions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "but"

Phrase: "treated with lactacystin 10 M,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0125179:lactacystin [Antibiotic,Organic Chemical]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "are"

Phrase: "also"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.173: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  In the present work we have evaluated the hypothesis that -synuclein expression levels may alter proteasome activity and function. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In the present work"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0681460:reference work [Intellectual Product]
   760   C0043227:Work [Occupational Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]

Phrase: "we"

Phrase: "have"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that -synuclein expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.174: If such a relationship exists, one would expect it to pop up clearly in the experimental conditions that have been analyzed. 

Phrase: "If"

Phrase: "such a relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "would"

Phrase: "expect"

Phrase: "it to pop up clearly in the experimental conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1517586:Experimental [Qualitative Concept]
   708   C0012634:condition [Disease or Syndrome]
   708   C0348080:Condition [Qualitative Concept]
   708   C1705253:Condition [Conceptual Entity]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.175: First we analyzed mice brains, either with no -synuclein expression (knock-out mice), normal levels of -synuclein (wt mice), or transgenic for human -synuclein A30P (with 1015-fold overexpression of -syn A30P in many brain areas). 

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "mice brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "either with no -synuclein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(knock-out mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C0560617:knock out [Injury or Poisoning]
   734   C1522225:Knock-out [Experimental Model of Disease]

Phrase: ")"

Phrase: ","

Phrase: "normal levels of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(wt mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "transgenic for human -synuclein A30P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003069:Transgenic [Animal]

Phrase: "("

Phrase: "with 1015-fold overexpression of -syn A30P"

Phrase: "in many brain areas"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0205146:areas [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0017446:Area [Geographic Area]

Phrase: ")."
Processing 00000000.tx.176: We found no significant difference in proteasome peptidase activities, - and -subunit (constitutive and inducible) and PA28 expression, in the striatum and ventral midbrain (substantia nigra and ventral tegmental area) brain areas, regions considered highly relevant to PD pathology. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant difference in proteasome peptidase activities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "-"

Phrase: "and -"

Phrase: "subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711351:Subunit [Quantitative Concept]

Phrase: "(constitutive"

Phrase: "and"

Phrase: "inducible"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Inducible [Functional Concept]
  1000   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "PA28 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the striatum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   827   C1704448:Ventral [Spatial Concept]
   755   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "brain areas,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0205146:areas [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0017446:Area [Geographic Area]

Phrase: "regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "highly relevant to PD pathology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.177: We also did not find changes in other brain areas examined, like the cerebral cortex and cerebellum, even in brains from A30P transgenic animals that show some motor disturbances (35). 

Phrase: "We also"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "changes in other brain areas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "like the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "even in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0006104:Brains [Body Part, Organ, or Organ Component]
   756 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from A30P transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003069:Animals, Transgenic [Animal]
   827   C0003062:Animals [Animal]

Phrase: "that"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "some motor disturbances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699787:Disturbance [Qualitative Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.178: Similar to what we found in transgenic mice, the overexpression of EYFP fusion constructs of human -syn wild type or their point variants (A30P and A53T) in PC12 cells has no significant effect in proteasome peptidase activity or expression of proteasome subunits and PA28 . In addition, similar results were obtained with cells transfected with untagged -syn wt and A30P variant (data not shown). 

Phrase: "Similar to what"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "we"

Phrase: "found in transgenic mice,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "the overexpression of EYFP fusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "constructs of human -syn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086418:Human [Human]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2827421:Construct [Classification]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "their point variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "(A30P"

Phrase: "and"

Phrase: "A53T"

Phrase: ")"

Phrase: "in PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "no significant effect in proteasome peptidase activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "expression of proteasome subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PA28 ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1166811:PA28 [Cell Component]

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1301820:Obtained [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1706701:Obtain [Activity]
   756 E C1948049:Cell [Spatial Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "transfected with untagged -syn wt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2700323:WT [Fish]

Phrase: "and"

Phrase: "A30P variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.179: The results on proteasome peptidase activities seem in contrast with results published by other groups as briefly mentioned in the Introduction. 

Phrase: "The results on proteasome peptidase activities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "seem in contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1979874:Contrast [Qualitative Concept]

Phrase: "with results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "published by other groups"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0034037:Published [Occupational Activity]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1704324:Published [Intellectual Product]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "as"

Phrase: "briefly"

Phrase: "mentioned in the Introduction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1293116:Introduction [Health Care Activity]
   770   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.180: Snyder et al. 

Phrase: "Snyder et al."
Processing 00000000.tx.181: (27) reported a 50% decrease in the chymotrypsin-like activity in stably (but not in transiently) transfected BME-17 cells with human -syn wt. 

Phrase: "(27"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a 50% decrease in the chymotrypsin-like activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "in stably"

Phrase: "("

Phrase: "but"

Phrase: "not in transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: ")"

Phrase: "transfected BME-17 cells with human -syn wt."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0427861:Human cells [Laboratory or Test Result]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.182: Tanaka et al. 

Phrase: "Tanaka et al."
Processing 00000000.tx.183: (17) report a small reduction of proteasome peptidase activity in PC12 cells stably transfected with human -syn A30P, (22.1, 17, and 24% reduction in the chymotrypsin-like, trypsin-like, and post-glutamyl hydrolase activities, respectively) but no change in peptidase activity when they overexpressed -syn wt. 

Phrase: "(17"

Phrase: ")"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "a small reduction of proteasome peptidase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2267000:Reduction Activity [Molecular Function]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in PC12 cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with human -syn A30P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086418:Human [Human]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(22.1,"

Phrase: "17,"

Phrase: "and"

Phrase: "24% reduction in the chymotrypsin-like, trypsin-like,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "post-glutamyl hydrolase activities,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   844   C1149632:hydrolase activity [Molecular Function]
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "but"

Phrase: "no change in peptidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "when"

Phrase: "they"

Phrase: "overexpressed -syn wt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2700323:WT [Fish]
   793   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.184: Similarly, Stefanis et al. 

Phrase: "Similarly,"

Phrase: "Stefanis et al."
Processing 00000000.tx.185: (19) report a small reduction of the chymotrypsin-like activity (2035%, the only peptidase activity measured in this work) in PC12 cells overexpressing -syn A53T, but no difference was observed in cell lines overexpressing -syn wt. 

Phrase: "(19"

Phrase: ")"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "a small reduction of the chymotrypsin-like activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2267000:Reduction Activity [Molecular Function]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(2035%,"

Phrase: "the only peptidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150095:peptidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "measured in this work"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0043227:Work [Occupational Activity]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: ")"

Phrase: "in PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing -syn A53T,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1514559:overexpress [Genetic Function]

Phrase: "but"

Phrase: "no difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressing -syn wt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2700323:WT [Fish]
   793   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.186: Except for the report of Snyder et al. 

Phrase: "Except for the report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "of Snyder et al."
Processing 00000000.tx.187: (27), the results of the other two groups agree with the results presented here that overexpression of -syn wt does not produce any significant changes in the peptidase activities of the proteasome. 

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "the results of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "other two groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "agree with the results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3641827:Agree [Intellectual Product]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "that overexpression of -syn wt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2700323:WT [Fish]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "produce"

Phrase: "any significant changes in the peptidase activities of the proteasome."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   706 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.188: The reported changes in proteasome peptidase activities in crude extracts from cells overexpressing the two -syn variants (A30P and A53T) are small, 1735%, and no explanation was given to these findings. 

Phrase: "The reported changes in proteasome peptidase activities"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0025320:The change [Physiologic Function]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "in crude extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1258023:Crude Extracts [Chemical]
   827   C2828366:Extract [Substance]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the two -syn variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variants [Qualitative Concept]

Phrase: "(A30P"

Phrase: "and"

Phrase: "A53T"

Phrase: ")"

Phrase: "are"

Phrase: "small, 1735%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]

Phrase: "and"

Phrase: "no explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681841:Explanation [Intellectual Product]

Phrase: "was"

Phrase: "given to these findings."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3244317:given [Intellectual Product]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C1947971:Give [Functional Concept]
   737 E C2825141:Finding [Finding]
Processing 00000000.tx.189: The amount of -synuclein present in the crude cell extracts from overexpressing cell lines could, if measurements of proteasome peptidase activity are not done with careful control of the assay conditions, cause variable inhibition of proteasomal peptidase activities. 

Phrase: "The amount of -synuclein present in the crude cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "extracts from overexpressing cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0007600:Cell lines [Cell]
   797   C0007592:Cell Extracts [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2828366:Extract [Substance]
   726   C1514559:overexpress [Genetic Function]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "could"

Phrase: ","

Phrase: "if"

Phrase: "measurements of proteasome peptidase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:measurements [Functional Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "done with careful control of the assay conditions,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C0243148:control [Qualitative Concept]
   744   C1272695:Done [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2746065:Done [Temporal Concept]
   744   C3274648:Control [Qualitative Concept]
   711   C0012634:condition [Disease or Syndrome]
   711   C0348080:Condition [Qualitative Concept]
   711   C1705253:Condition [Conceptual Entity]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "variable inhibition of proteasomal peptidase activities."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   748   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
Processing 00000000.tx.190: In this context, it is worth recalling that synuclein and EYFP-synuclein fusion protein (and their synuclein variants) are direct substrates of the 20 and 26 S proteasome and that the synthetic fluorogenic substrates used for the peptidase assay of the proteasome inhibit the degradation of synuclein, and vice versa, as expected (13).2 As the method of assay of proteasome peptidase activity varies somewhat between the different groups, we have also performed the assay of the peptidase activities in the presence of glycerol and ATP to preserve the 26 S proteasome complex and homogenizing cells by Dounce (19) and assaying the peptidase activities in the presence or in the absence of 5 mM magnesium-ATP. 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "it"

Phrase: "is worth recalling"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0034770:recalling [Mental Process]
   756 E C1705180:Recall [Governmental or Regulatory Activity]
   756 E C2361119:Recall [Clinical Attribute]

Phrase: "that synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "EYFP-synuclein fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "and"

Phrase: "their synuclein variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "direct substrates of the 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "26 S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "that"

Phrase: "the synthetic fluorogenic substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0016349:Fluorogenic Substrate [Indicator, Reagent, or Diagnostic Aid]
   793   C1710236:Substrate [Manufactured Object]

Phrase: "used for the peptidase assay of the proteasome"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   750   C1524063:Use of [Functional Concept]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0243073:assay [Qualitative Concept]
   744   C1273517:used [Finding]
   744   C1325620:proteasome [Cell Component]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1752727:Proteasome [Molecular Function]
   744   C1947941:Peptidase [Enzyme]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the degradation of synuclein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "vice versa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(13"

Phrase: ").2 As the method of assay of proteasome peptidase activity"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   760   C1150095:peptidase activity [Molecular Function]
   757   C1622946:proteasome activity [Molecular Function]
   739   C0005507:Assay [Laboratory Procedure]
   739   C0025663:Method [Intellectual Product]
   739   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205177:Activity [Functional Concept]
   739   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0243073:assay [Qualitative Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0449851:Method [Functional Concept]
   739   C0740116:+2 [Quantitative Concept]
   739   C0871511:METHOD [Intellectual Product]
   739   C1325620:proteasome [Cell Component]
   739   C1510438:Assay [Laboratory Procedure]
   739   C1561536:*Activity [Idea or Concept]
   739   C1752727:Proteasome [Molecular Function]
   739   C1947941:Peptidase [Enzyme]
   739   C2827735:2+ [Quantitative Concept]
   739   C2981700:2+ [Classification]
   722   C1704532:Active Method [Therapeutic or Preventive Procedure]

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "somewhat between the different groups,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C2984079:Somewhat [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "also"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the assay of the peptidase activities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ATP to"

Phrase: "preserve"

Phrase: "the 26 S proteasome complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
   756   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1166804:26S proteasome [Cell Component]

Phrase: "and"

Phrase: "homogenizing cells by Dounce"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(19"

Phrase: ")"

Phrase: "and"

Phrase: "assaying"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "the peptidase activities in the presence"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   773   C1150095:peptidase activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "or in the absence of 5 mM magnesium-ATP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0024467:Magnesium [Element, Ion, or Isotope]
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]
   742   C2348270:MAGNESIUM [Element, Ion, or Isotope]
Processing 00000000.tx.191: Once again the results showed no significant difference in the peptidase activities of the proteasome. 

Phrase: "Once"

Phrase: "again"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no significant difference in the peptidase activities of the proteasome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.192: All the data presented clearly allow us to conclude that -syn overexpression has no clear significant effect on proteasome peptidase activity or expression. 

Phrase: "All"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "clearly"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that -syn overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "has"

Phrase: "no clear significant effect on proteasome peptidase activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.193: Even in the case that a small reduction of peptidase activity of the proteasome is observed in cell lines overexpressing -syn and their variants, we have shown here that -synuclein (wt, A30P, and A53T) overexpression does not affect proteasome assembly or the turnover rate of short half-life proteins, like Ib. 

Phrase: "Even in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]

Phrase: "that"

Phrase: "a small reduction of peptidase activity of the proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C2267000:Reduction Activity [Molecular Function]
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressing -syn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514559:overexpress [Genetic Function]

Phrase: "and"

Phrase: "their variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "A30P,"

Phrase: "and"

Phrase: "A53T"

Phrase: ")"

Phrase: "overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "proteasome assembly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1523886:proteasome assembly [Molecular Function]
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "or"

Phrase: "the turnover rate of short half-life proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "like Ib."
Processing 00000000.tx.194: These results clearly indicate that proteasome function is not significantly impaired by -syn overexpression in a cellular context. 

Phrase: "These results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that proteasome function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "impaired by -syn overexpression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in a cellular context."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449255:Context [Finding]
   861   C0542559:Context [Functional Concept]
Processing 00000000.tx.195: Another question is the meaning of the results presented here to the understanding of PD pathology in human brain. 

Phrase: "Another question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "is"

Phrase: "the meaning of the results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0876919:Meaning [Idea or Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here to the understanding of PD pathology"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0030664:Pathology [Biomedical Occupation or Discipline]
   744   C0162340:Understanding [Mental Process]
   744   C0205469:pathology [Functional Concept]
   744   C0677042:pathology [Pathologic Function]

Phrase: "in human brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.196: No extrapolation can be made directly, as factors modifying synuclein or proteasome function may occur in PD patients (aging, oxidative stress) that could alter the cell homeostasis of synuclein synthesis and disposal. 

Phrase: "No extrapolation"

Phrase: "can"

Phrase: "be"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "directly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "as"

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "modifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392747:MODIFY [Functional Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "proteasome function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "may"

Phrase: "occur in PD patients"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: ")"

Phrase: "that"

Phrase: "could"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the cell homeostasis of synuclein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019868:Homeostasis [Biologic Function]

Phrase: "and"

Phrase: "disposal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707797:Disposal [Activity]
Processing 00000000.tx.197: In a preliminary approach we have analyzed brain samples from three PD patients with Lewy body pathology in many brain areas including substantia nigra, as it is usual observation at post-mortem studies because of the marked heterogeneity in the clinical and pathological phenotype of PD patients (39). 

Phrase: "In a preliminary approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "analyzed brain samples from three PD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "with Lewy body pathology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "in many brain areas"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0205146:areas [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0017446:Area [Geographic Area]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "substantia nigra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "it"

Phrase: "is"

Phrase: "usual observation at post-mortem"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1964257:Observation [Diagnostic Procedure]

Phrase: "studies because of the marked heterogeneity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1867118:Marked heterogeneity [Finding]
   753   C0019409:Heterogeneity [Qualitative Concept]
   753   C0522501:Marked [Qualitative Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0947630:studies [Laboratory Procedure]
   753   C1706089:Marked [Qualitative Concept]
   753   C2603343:Study [Research Activity]

Phrase: "in the clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological phenotype of PD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.198: These preliminary results confirmed our data from mice, namely that proteasome peptidase activity is also higher in human brain striatum than in the substantia nigra pars compacta. 

Phrase: "These preliminary results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1548161:Preliminary results [Idea or Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "our data from mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "namely"

Phrase: "that proteasome peptidase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1622946:proteasome activity [Molecular Function]
   901   C1150095:peptidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "also higher in human brain striatum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in the substantia nigra pars compacta."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]
Processing 00000000.tx.199: Furthermore, with respect to age-matched controls, we observed no significant changes in proteasomal subunit expression levels (either or , using tubulin or protein disulfide isomerase as controls of protein loading). 

Phrase: "Furthermore,"

Phrase: "with respect to age-matched controls,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0001779:Age [Organism Attribute]
   827   C0150103:matched [Research Activity]
   827   C1708943:Matched [Qualitative Concept]
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "no significant changes in proteasomal subunit expression levels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   750   C0442739:No change [Finding]
   750   C1548568:No change [Intellectual Product]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "(either"

Phrase: "or"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "or"

Phrase: "protein disulfide isomerase as controls of protein loading"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0072354:Protein Disulfide Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
           Disulfide Isomerase
   800   C1150347:protein disulfide-isomerase [Molecular Function]
   770   C1418224:DISULFIDE ISOMERASE [Gene or Genome]
   744   C0012771:disulfide [Chemical Viewed Structurally]
   744   C0022202:Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.200: These preliminary results, obtained with the only human samples made available to us until now, are in sharp contrast with the reported decrease in proteasomal peptidase activities and the unexplained reduction of expression of -subunits (but not -subunits) of the proteasome in the substantia nigra of patients with sporadic PD (23, 24). 

Phrase: "These preliminary results,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1548161:Preliminary results [Idea or Concept]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "obtained with the only human samples"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   767   C1277697:Sample obtained [Finding]
   753   C0086418:Human [Human]
   753   C0205171:Only [Quantitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1720467:Only [Intellectual Product]
   719   C0370003:Sample [Substance]
   719 E C1706701:Obtain [Activity]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "available to us"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "until"

Phrase: "now,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "are in sharp contrast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1444775:Sharp [Finding]
   770   C1539835:SHARP [Gene or Genome]
   770   C1551058:Are [Quantitative Concept]
   770   C1979874:Contrast [Qualitative Concept]

Phrase: "with the reported decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "in proteasomal peptidase activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C1150095:peptidase activity [Molecular Function]
   861   C1622946:proteasome activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the unexplained reduction of expression of -subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "but"

Phrase: "not -subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: ")"

Phrase: "of the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with sporadic PD"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.201: Our preliminary data are in better agreement with those reported by other authors that found no changes in proteasome peptidase activities in brain regions affected with dementia with Lewy body pathology (26). 

Phrase: "Our preliminary data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are in better agreement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332272:Better [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with those"

Phrase: "reported by other authors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1709908:Reported By [Group]
   770   C0221193:Authors [Professional or Occupational Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no changes in proteasome peptidase activities"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C0442739:No change [Finding]
   773   C1548568:No change [Intellectual Product]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "in brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "affected with dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0392760:Affected [Functional Concept]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "with Lewy body pathology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.202: We believe, in agreement with the comments in a recent review (40), that the study of proteasome activity and subunit expression in the human brain from PD patients and other synucleinopathies require further detailed examination before reaching the conclusion that proteasome function is impaired in substantia nigra of PD patients. 

Phrase: "We"

Phrase: "believe"

Phrase: ","

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282411:Comments [Intellectual Product]
  1000   C0947611:comments [Intellectual Product]
  1000   C1705247:Comments [Conceptual Entity]

Phrase: "in a recent review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282443:Review [Intellectual Product]
   861   C1552617:Review [Idea or Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "the study of proteasome activity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C2348552:Study Activity [Research Activity]
   762 E C2347179:Active Study [Functional Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "subunit expression in the human brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from PD patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "and"

Phrase: "other synucleinopathies"

Phrase: "require"

Phrase: "further detailed examination before reaching"

Phrase: "the conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "that proteasome function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "impaired in substantia nigra of PD patients."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   770   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0221099:Impaired [Functional Concept]
   744   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.203: Finally, we want to stress that the results presented in this work are not in contradiction with the fact, shown by several laboratories, that proteasome inhibition causes aggregation of -syn and their point variants when overexpressed (we also obtained similar results with the EYFP fusion and untagged synuclein constructs). 

Phrase: "Finally,"

Phrase: "we"

Phrase: "want to stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0038435:Stress [Finding]
   718 E C0231297:Stressful [Functional Concept]

Phrase: "that"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in this work"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0043227:Work [Occupational Activity]
   770   C0449450:Presented [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "are"

Phrase: "not in contradiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "with the fact,"

Phrase: "shown by several laboratories,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C1619828:Laboratories [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "that proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "aggregation of -syn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their point variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "when"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "("

Phrase: "we also"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "similar results with the EYFP fusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and"

Phrase: "untagged synuclein constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: ")."
Processing 00000000.tx.204: Further studies are required to fully understand the degradation pathway of the long half-life -syn protein (11) and whether aggregation or fibrillation of -syn actually inhibits proteasome activity in the cell, maybe through binding to the S6' subunit of the 19 S proteasome complex (27).  

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the degradation pathway of the long half-life -syn protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1511758:Degradation Pathway [Conceptual Entity]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "whether"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "or"

Phrase: "fibrillation of -syn actually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proteasome activity in the cell,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1622946:proteasome activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "maybe through binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to the S6' subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "of the 19 S proteasome complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.205: FOOTNOTES  * This work was supported by Comisin Interministerial de Ciencia y Tecnologa (SAF2002-00566, GEN2001-4851) and CAM (08.5/0041/2002). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Comisin Interministerial de Ciencia y Tecnologa"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0011198:DE [Geographic Area]
   744   C0017480:DE [Geographic Area]
   744   C1521721:Supported [Conceptual Entity]
   744   C3541240:DE [Idea or Concept]
   711 E C0183683:Support [Medical Device]

Phrase: "(SAF2002-00566,"

Phrase: "GEN2001-4851"

Phrase: ")"

Phrase: "and"

Phrase: "CAM (08.5/0041/2002"

Phrase: ")."
Processing 00000000.tx.206: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.207: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.208: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.209: Recipient of a Postdoctoral Fellowship from CAM.  

Phrase: "Recipient of a Postdoctoral Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709854:Recipient [Human]

Phrase: "from CAM."
Processing 00000000.tx.210: Recipient of a Predoctoral Fellowship from MCYT; 

Phrase: "Recipient of a Predoctoral Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709854:Recipient [Human]

Phrase: "from MCYT"

Phrase: ";"
Processing 00000000.tx.211: || Recipient of a Predoctoral Fellowship from Fundacin la Caixa.  

Phrase: "|| Recipient of a Predoctoral Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709854:Recipient [Human]

Phrase: "from Fundacin la Caixa."
Processing 00000000.tx.212: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.213: Fax: 34-91-585-4401; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "34-91-585-4401"

Phrase: ";"
Processing 00000000.tx.214: E-mail: joseg.castano{at}uam.es . 1 The abbreviations used are: PD, Parkinson disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "joseg.castano{at}uam.es . 1"

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PD,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "Parkinson disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ";"
Processing 00000000.tx.215: -syn, -synuclein; 

Phrase: "-syn, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.216: Tg, transgenic; 

Phrase: "Tg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337445:TG [Laboratory Procedure]

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: ";"
Processing 00000000.tx.217: wt, wild type; 

Phrase: "wt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.218: EYFP, enhanced yellow fluorescent protein; 

Phrase: "EYFP,"

Phrase: "enhanced yellow fluorescent protein"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0221205:Yellow [Qualitative Concept]
   812   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C2349975:Enhanced [Activity]
   741 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.219: KO, knock-out. 

Phrase: "KO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "knock-out."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0560617:knock out [Injury or Poisoning]
  1000   C1522225:Knock-out [Experimental Model of Disease]
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.220: 2 B. 

Phrase: "2 B."
Processing 00000000.tx.221: Alvarez-Castelao, I. 

Phrase: "Alvarez-Castelao,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.222: Mayo, and J. 

Phrase: "Mayo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0454788:Mayo [Geographic Area]
  1000   C1077578:mayo [Plant]

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.223: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.224: Castao, unpublished results.  

Phrase: "Castao,"

Phrase: "unpublished results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.225: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Gomez-Tortosa, E., Irizarry, M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Gomez-Tortosa,"

Phrase: "E.,"

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.226: C., Gomez-Isla, T., and Hyman, B. 

Phrase: "C., Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.227: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.228: (2000) Ann. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.229: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.230: Y. 

Phrase: "Y."
Processing 00000000.tx.231: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.232: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.233: 920, 915[Abstract/Free FullText] Spillantini, M. 

Phrase: "920,"

Phrase: "915"

Phrase: "[Abstract/Free FullText"

Phrase: "] Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.234: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.235: (2000) Ann. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.236: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.237: Y. 

Phrase: "Y."
Processing 00000000.tx.238: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.239: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.240: 920, 1627[Abstract/Free FullText] Irizarry, M. 

Phrase: "920,"

Phrase: "1627"

Phrase: "[Abstract/Free FullText"

Phrase: "] Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.241: C., Kim, T. 

Phrase: "C., Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.242: W., McNamara, M., Tanzi, R. 

Phrase: "W., McNamara,"

Phrase: "M."

Phrase: ","

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.243: E., George, J. 

Phrase: "E.,"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.244: M., Clayton, D. 

Phrase: "M."

Phrase: ","

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.245: F., and Hyman, B. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.246: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.247: (1996) J Neuropathol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J Neuropathol."
Processing 00000000.tx.248: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.249: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.250: 55, 889895[Medline] [OrderarticleviaInfotrieve] Spillantini, M. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "889895"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.251: G., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.252: A., Jakes, R., Hasegawa, M., and Goedert, M. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.253: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.254: Natl. 

Phrase: "Natl."
Processing 00000000.tx.255: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.256: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.257: U. 

Phrase: "U."
Processing 00000000.tx.258: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.259: A. 

Phrase: "A."
Processing 00000000.tx.260: 95, 64696473[Abstract/Free FullText] Takeda, A., Mallory, M., Sundsmo, M., Honer, W., Hansen, L., and Masliah, E. 

Phrase: "95,"

Phrase: "64696473"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takeda,"

Phrase: "A.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Sundsmo,"

Phrase: "M."

Phrase: ","

Phrase: "Honer,"

Phrase: "W.,"

Phrase: "Hansen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.261: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.262: J Pathol. 

Phrase: "J Pathol."
Processing 00000000.tx.263: 152, 367372[Abstract] Polymeropoulos, M. 

Phrase: "152,"

Phrase: "367372"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.264: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.265: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos,"

Phrase: "E."
Processing 00000000.tx.266: S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. 

Phrase: "S."

Phrase: ","

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Athanassiadou,"

Phrase: "A.,"

Phrase: "Papapetropoulos,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnson,"

Phrase: "W."
Processing 00000000.tx.267: G., Lazzarini, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A."
Processing 00000000.tx.268: M., Duvoisin, R. 

Phrase: "M."

Phrase: ","

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.269: C., Di Iorio, G., Golbe, L. 

Phrase: "C., Di Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.270: I., and Nussbaum, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.271: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.272: (1997) Science 276, 20452047[Abstract/Free FullText] Zarranz, J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "20452047"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zarranz,"

Phrase: "J."
Processing 00000000.tx.273: J., Alegre, J., Gomez-Esteban, J. 

Phrase: "J.,"

Phrase: "Alegre,"

Phrase: "J.,"

Phrase: "Gomez-Esteban,"

Phrase: "J."
Processing 00000000.tx.274: C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B., Llorens, V., Gomez, T. 

Phrase: "C., Lezcano,"

Phrase: "E.,"

Phrase: "Ros,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hoenicka,"

Phrase: "J.,"

Phrase: "Rodriguez,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Atares,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Llorens,"

Phrase: "V.,"

Phrase: "Gomez,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.275: E., del Ser, T., Munoz, D. 

Phrase: "E.,"

Phrase: "del Ser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Munoz,"

Phrase: "D."
Processing 00000000.tx.276: G., and De Yebenes, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "De Yebenes,"

Phrase: "J."
Processing 00000000.tx.277: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.278: (2004) Ann. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.279: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.280: 55, 164173[CrossRef][Medline] [OrderarticleviaInfotrieve] Conway, K. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "164173"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.281: A., Harper, J. 

Phrase: "A.,"

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.282: D., and Lansbury, P. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.283: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.284: (2000) Biochemistry 39, 25522563[CrossRef][Medline] [OrderarticleviaInfotrieve] Dawson, V. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochemistry 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "25522563"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V."
Processing 00000000.tx.285: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.286: (2000) Science 288, 631632[Free FullText] Maries, E., Dass, B., Collier, T. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 288,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "631632"

Phrase: "[Free FullText"

Phrase: "] Maries,"

Phrase: "E.,"

Phrase: "Dass,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
   966   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Collier,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.287: J., Kordower, J. 

Phrase: "J.,"

Phrase: "Kordower,"

Phrase: "J."
Processing 00000000.tx.288: H., and Steece-Collier, K. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Steece-Collier,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.289: (2003) Nat. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.290: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.291: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.292: 4, 727738[CrossRef][Medline] [OrderarticleviaInfotrieve] Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. 

Phrase: "4,"

Phrase: "727738"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Okochi,"

Phrase: "M."

Phrase: ","

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Koyama,"

Phrase: "A.,"

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Meijer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kahle,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.293: J., and Haass, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.294: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.295: Biol. 

Phrase: "Biol."
Processing 00000000.tx.296: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.297: 275, 390397[Abstract/Free FullText] Tofaris, G. 

Phrase: "275,"

Phrase: "390397"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tofaris,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.298: K., Layfield, R., and Spillantini, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Layfield,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.299: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.300: (2001) FEBS Lett. 

Phrase: "(2001"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.301: 509, 2226[CrossRef][Medline] [OrderarticleviaInfotrieve] Liu, C. 

Phrase: "509,"

Phrase: "2226"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Liu,"

Phrase: "C."
Processing 00000000.tx.302: W., Corboy, M. 

Phrase: "W., Corboy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.303: J., DeMartino, G. 

Phrase: "J.,"

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.304: N., and Thomas, P. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Thomas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.305: J. 

Phrase: "J."
Processing 00000000.tx.306: (2003) Science 299, 408411[Abstract/Free FullText] McLean, P. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 299,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "408411"

Phrase: "[Abstract/Free FullText"

Phrase: "] McLean,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.307: J., Kawamata, H., and Hyman, B. 

Phrase: "J.,"

Phrase: "Kawamata,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.308: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.309: (2001) Neuroscience 104, 901912[CrossRef][Medline] [OrderarticleviaInfotrieve] Petrucelli, L., O'Farrell, C., Lockhart, P. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neuroscience 104,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "901912"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.310: J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J., and Cookson, M. 

Phrase: "J.,"

Phrase: "Baptista,"

Phrase: "M."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vink,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Cookson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.311: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.312: (2002) Neuron 36, 10071019[Medline] [OrderarticleviaInfotrieve] Sawada, H., Kohno, R., Kihara, T., Izumi, Y., Sakka, N., Ibi, M., Nakanishi, M., Nakamizo, T., Yamakawa, K., Shibasaki, H., Yamamoto, N., Akaike, A., Inden, M., Kitamura, Y., Taniguchi, T., and Shimohama, S. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuron 36,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "10071019"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sawada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kohno,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kihara,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Izumi,"

Phrase: "Y.,"

Phrase: "Sakka,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ibi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325469:ibi [Bird]

Phrase: "M."

Phrase: ","

Phrase: "Nakanishi,"

Phrase: "M."

Phrase: ","

Phrase: "Nakamizo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamakawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shibasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Akaike,"

Phrase: "A.,"

Phrase: "Inden,"

Phrase: "M."

Phrase: ","

Phrase: "Kitamura,"

Phrase: "Y.,"

Phrase: "Taniguchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Shimohama,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.313: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.314: Biol. 

Phrase: "Biol."
Processing 00000000.tx.315: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.316: 279, 1071010719[Abstract/Free FullText] Tanaka, Y., Engelender, S., Igarashi, S., Rao, R. 

Phrase: "279,"

Phrase: "1071010719"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tanaka,"

Phrase: "Y.,"

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Igarashi,"

Phrase: "S."

Phrase: ","

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.317: K., Wanner, T., Tanzi, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wanner,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.318: E., Sawa, A., Dawson, L., Dawson, T. 

Phrase: "E.,"

Phrase: "Sawa,"

Phrase: "A.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.319: M., and Ross, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."
Processing 00000000.tx.320: A. 

Phrase: "A."
Processing 00000000.tx.321: (2001) Hum. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.322: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.323: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.324: 10, 919926[Abstract/Free FullText] Rideout, H. 

Phrase: "10,"

Phrase: "919926"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rideout,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.325: J., Larsen, K. 

Phrase: "J.,"

Phrase: "Larsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.326: E., Sulzer, D., and Stefanis, L. 

Phrase: "E.,"

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Stefanis,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.327: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.328: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.329: 78, 899908[CrossRef][Medline] [OrderarticleviaInfotrieve] Stefanis, L., Larsen, K. 

Phrase: "78,"

Phrase: "899908"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stefanis,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Larsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.330: E., Rideout, H. 

Phrase: "E.,"

Phrase: "Rideout,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.331: J., Sulzer, D., and Greene, L. 

Phrase: "J.,"

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Greene,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.332: A. 

Phrase: "A."
Processing 00000000.tx.333: (2001) J Neurosci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J Neurosci."
Processing 00000000.tx.334: 21, 95499560[Abstract/Free FullText] Lehmensiek, V., Tan, E. 

Phrase: "21,"

Phrase: "95499560"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lehmensiek,"

Phrase: "V.,"

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "E."
Processing 00000000.tx.335: M., Schwarz, J., and Storch, A. 

Phrase: "M."

Phrase: ","

Phrase: "Schwarz,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Storch,"

Phrase: "A."
Processing 00000000.tx.336: (2002) Neuroreport 13, 12791283[CrossRef][Medline] [OrderarticleviaInfotrieve] Tanaka, M., Kim, Y. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuroreport 13,"

Phrase: "12791283"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tanaka,"

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "Y."
Processing 00000000.tx.337: M., Lee, G., Junn, E., Iwatsubo, T., and Mouradian, M. 

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Junn,"

Phrase: "E.,"

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Mouradian,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.339: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.340: Biol. 

Phrase: "Biol."
Processing 00000000.tx.341: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.342: 279, 46254631[Abstract/Free FullText] Waelter, S., Boeddrich, A., Lurz, R., Scherzinger, E., Lueder, G., Lehrach, H., and Wanker, E. 

Phrase: "279,"

Phrase: "46254631"

Phrase: "[Abstract/Free FullText"

Phrase: "] Waelter,"

Phrase: "S."

Phrase: ","

Phrase: "Boeddrich,"

Phrase: "A.,"

Phrase: "Lurz,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Scherzinger,"

Phrase: "E.,"

Phrase: "Lueder,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lehrach,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wanker,"

Phrase: "E."
Processing 00000000.tx.343: E. 

Phrase: "E."
Processing 00000000.tx.344: (2001) Mol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.345: Biol. 

Phrase: "Biol."
Processing 00000000.tx.346: Cell 12, 13931407[Abstract/Free FullText] McNaught, K. 

Phrase: "Cell 12,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "13931407"

Phrase: "[Abstract/Free FullText"

Phrase: "] McNaught,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.347: S., and Jenner, P. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Jenner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.348: (2001) Neurosci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.349: Lett. 

Phrase: "Lett."
Processing 00000000.tx.350: 297, 191194[CrossRef][Medline] [OrderarticleviaInfotrieve] McNaught, K. 

Phrase: "297,"

Phrase: "191194"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McNaught,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.351: S., Belizaire, R., Jenner, P., Olanow, C. 

Phrase: "S."

Phrase: ","

Phrase: "Belizaire,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jenner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Olanow,"

Phrase: "C."
Processing 00000000.tx.352: W., and Isacson, O. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Isacson,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.353: (2002) Neurosci. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.354: Lett. 

Phrase: "Lett."
Processing 00000000.tx.355: 326, 155158[CrossRef][Medline] [OrderarticleviaInfotrieve] McNaught, K. 

Phrase: "326,"

Phrase: "155158"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McNaught,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.356: S., Belizaire, R., Isacson, O., Jenner, P., and Olanow, C. 

Phrase: "S."

Phrase: ","

Phrase: "Belizaire,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Isacson,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Jenner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Olanow,"

Phrase: "C."
Processing 00000000.tx.357: W. 

Phrase: "W."
Processing 00000000.tx.358: (2003) Exp. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.359: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.360: 179, 3846[CrossRef][Medline] [OrderarticleviaInfotrieve] Tofaris, G. 

Phrase: "179,"

Phrase: "3846"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tofaris,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.361: K., Razzaq, A., Ghetti, B., Lilley, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Razzaq,"

Phrase: "A.,"

Phrase: "Ghetti,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lilley,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.362: S., and Spillantini, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.364: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.365: Biol. 

Phrase: "Biol."
Processing 00000000.tx.366: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.367: 278, 4440544411[Abstract/Free FullText] Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., and Wolozin, B. 

Phrase: "278,"

Phrase: "4440544411"

Phrase: "[Abstract/Free FullText"

Phrase: "] Snyder,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mensah,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Theisler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "J.,"

Phrase: "Matouschek,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.368: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.369: Biol. 

Phrase: "Biol."
Processing 00000000.tx.370: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.371: 278, 1175311759[Abstract/Free FullText] Lindersson, E., Beedholm, R., Hojrup, P., Moos, T., Gai, W., Hendil, K. 

Phrase: "278,"

Phrase: "1175311759"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lindersson,"

Phrase: "E.,"

Phrase: "Beedholm,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hojrup,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Moos,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234884:moos [Individual Behavior]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517505:GAI [Research Activity]

Phrase: "W.,"

Phrase: "Hendil,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.372: B., and Jensen, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.373: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.374: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.375: Biol. 

Phrase: "Biol."
Processing 00000000.tx.376: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.377: 279, 1292412934[Abstract/Free FullText] Singleton, A. 

Phrase: "279,"

Phrase: "1292412934"

Phrase: "[Abstract/Free FullText"

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A."
Processing 00000000.tx.378: B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Peuralinna,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Nussbaum,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Crawley,"

Phrase: "A.,"

Phrase: "Hanson,"

Phrase: "M."

Phrase: ","

Phrase: "Maraganore,"

Phrase: "D."

Phrase: ","

Phrase: "Adler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Cookson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.379: R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., and Gwinn-Hardy, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Muenter,"

Phrase: "M."

Phrase: ","

Phrase: "Baptista,"

Phrase: "M."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "D."

Phrase: ","

Phrase: "Blancato,"

Phrase: "J.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Gwinn-Hardy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.380: (2003) Science 302, 841[Free FullText] Xu, J., Kao, S. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 302,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "841"

Phrase: "[Free FullText"

Phrase: "] Xu,"

Phrase: "J.,"

Phrase: "Kao,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.381: Y., Lee, F. 

Phrase: "Y.,"

Phrase: "Lee,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.382: J., Song, W., Jin, L. 

Phrase: "J.,"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "W.,"

Phrase: "Jin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.383: W., and Yankner, B. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.384: A. 

Phrase: "A."
Processing 00000000.tx.385: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.386: Med. 

Phrase: "Med."
Processing 00000000.tx.387: 8, 600606[CrossRef][Medline] [OrderarticleviaInfotrieve] Kingsbury, A. 

Phrase: "8,"

Phrase: "600606"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kingsbury,"

Phrase: "A."
Processing 00000000.tx.388: E., Daniel, S. 

Phrase: "E.,"

Phrase: "Daniel,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.389: E., Sangha, H., Eisen, S., Lees, A. 

Phrase: "E.,"

Phrase: "Sangha,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Eisen,"

Phrase: "S."

Phrase: ","

Phrase: "Lees,"

Phrase: "A."
Processing 00000000.tx.390: J., and Foster, O. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.391: J. 

Phrase: "J."
Processing 00000000.tx.392: (2004) Movement Disorders 19, 162170[CrossRef][Medline] [OrderarticleviaInfotrieve] Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Movement Disorders 19,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0026650:Movement Disorders [Disease or Syndrome]
   827   C0012634:Disorders [Disease or Syndrome]
   827   C0026649:Movement [Organism Function]

Phrase: "162170"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fukushima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Otero,"

Phrase: "D."
Processing 00000000.tx.393: A., Kondo, J., Ihara, Y., and Saitoh, T. 

Phrase: "A.,"

Phrase: "Kondo,"

Phrase: "J.,"

Phrase: "Ihara,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.394: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.395: Natl. 

Phrase: "Natl."
Processing 00000000.tx.396: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.397: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.398: U. 

Phrase: "U."
Processing 00000000.tx.399: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.400: A. 

Phrase: "A."
Processing 00000000.tx.401: 90, 1128211286[Abstract] Arribas, J., Arizti, P., and Castao, J. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "1128211286"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Arribas,"

Phrase: "J.,"

Phrase: "Arizti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Castao,"

Phrase: "J."
Processing 00000000.tx.402: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.403: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.404: Biol. 

Phrase: "Biol."
Processing 00000000.tx.405: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.406: 269, 1285812864[Abstract/Free FullText] Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W. 

Phrase: "269,"

Phrase: "1285812864"

Phrase: "[Abstract/Free FullText"

Phrase: "] Abeliovich,"

Phrase: "A.,"

Phrase: "Schmitz,"

Phrase: "Y.,"

Phrase: "Farinas,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Choi-Lundberg,"

Phrase: "D."

Phrase: ","

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "W."
Processing 00000000.tx.407: H., Castillo, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Castillo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.408: E., Shinsky, N., Verdugo, J. 

Phrase: "E.,"

Phrase: "Shinsky,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Verdugo,"

Phrase: "J."
Processing 00000000.tx.409: M., Armanini, M., Ryan, A., Hynes, M., Phillips, H., Sulzer, D., and Rosenthal, A. 

Phrase: "M."

Phrase: ","

Phrase: "Armanini,"

Phrase: "M."

Phrase: ","

Phrase: "Ryan,"

Phrase: "A.,"

Phrase: "Hynes,"

Phrase: "M."

Phrase: ","

Phrase: "Phillips,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Rosenthal,"

Phrase: "A."
Processing 00000000.tx.410: (2000) Neuron 25, 239252[Medline] [OrderarticleviaInfotrieve] Gomez-Isla, T., Irizarry, M. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuron 25,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "239252"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.411: C., Mariash, A., Cheung, B., Soto, O., Schrump, S., Sondel, J., Kotilinek, L., Day, J., Schwarzschild, M. 

Phrase: "C., Mariash,"

Phrase: "A.,"

Phrase: "Cheung,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Soto,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Schrump,"

Phrase: "S."

Phrase: ","

Phrase: "Sondel,"

Phrase: "J.,"

Phrase: "Kotilinek,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "J.,"

Phrase: "Schwarzschild,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: A., Cha, J. 

Phrase: "A.,"

Phrase: "Cha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420648:CHA [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.413: H., Newell, K., Miller, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Newell,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.414: W., Ueda, K., Young, A. 

Phrase: "W., Ueda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "A."
Processing 00000000.tx.415: B., Hyman, B. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.416: T., and Ashe, K. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ashe,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.417: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.418: (2003) Neurobiol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.419: Aging 24, 245258[CrossRef][Medline] [OrderarticleviaInfotrieve] Rodriguez-Vilario, S., Arribas, J., Arizti, P., and Castao, J. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "24,"

Phrase: "245258"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rodriguez-Vilario,"

Phrase: "S."

Phrase: ","

Phrase: "Arribas,"

Phrase: "J.,"

Phrase: "Arizti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Castao,"

Phrase: "J."
Processing 00000000.tx.420: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.421: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.422: Biol. 

Phrase: "Biol."
Processing 00000000.tx.423: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.424: 275, 65926599[Abstract/Free FullText] Arribas, J., and Castao, J. 

Phrase: "275,"

Phrase: "65926599"

Phrase: "[Abstract/Free FullText"

Phrase: "] Arribas,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Castao,"

Phrase: "J."
Processing 00000000.tx.425: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.426: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.427: Biol. 

Phrase: "Biol."
Processing 00000000.tx.428: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.429: 265, 1396913973[Abstract/Free FullText] Nieto, A., Mira, E., and Castao, J. 

Phrase: "265,"

Phrase: "1396913973"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nieto,"

Phrase: "A.,"

Phrase: "Mira,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Castao,"

Phrase: "J."
Processing 00000000.tx.430: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.431: (1990) Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.432: J. 

Phrase: "J."
Processing 00000000.tx.433: 267, 317323[Medline] [OrderarticleviaInfotrieve] Foltynie, T., Brayne, C., and Barker, R. 

Phrase: "267,"

Phrase: "317323"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Foltynie,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Brayne,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Barker,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.434: A. 

Phrase: "A."
Processing 00000000.tx.435: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.436: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.437: 249, 138145[Medline] [OrderarticleviaInfotrieve] Ciechanover, A., and Brundin, P. 

Phrase: "249,"

Phrase: "138145"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ciechanover,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Brundin,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.438: (2003) Neuron 40, 427446[Medline] [OrderarticleviaInfotrieve]

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 40,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0027882:Neuron [Cell]
   861   C0439509:/40 [Temporal Concept]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "427446"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

